<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="2.3">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2022.856686</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Different Drugs, Same End: Ultrastructural Hallmarks of Autophagy in Pathogenic Protozoa</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Pedra-Rezende</surname><given-names>Yasmin</given-names></name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Macedo</surname><given-names>Isabela S.</given-names></name>
<xref rid="aff2" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Midlej</surname><given-names>Victor</given-names></name>
<xref rid="aff3" ref-type="aff"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1680996/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Mariante</surname><given-names>Rafael M.</given-names></name>
<xref rid="aff2" ref-type="aff"><sup>2</sup></xref>
<xref rid="c001" ref-type="corresp"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/426983/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Menna-Barreto</surname><given-names>Rubem F. S.</given-names></name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<xref rid="c001" ref-type="corresp"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/644155/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Laborat&#x00F3;rio de Biologia Celular, Instituto Oswaldo Cruz, Fiocruz</institution>, <addr-line>Rio de Janeiro</addr-line>, <country>Brazil</country></aff>
<aff id="aff2"><sup>2</sup><institution>Laborat&#x00F3;rio de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz</institution>, <addr-line>Rio de Janeiro</addr-line>, <country>Brazil</country></aff>
<aff id="aff3"><sup>3</sup><institution>Laborat&#x00F3;rio de Ultraestrutura Celular, Instituto Oswaldo Cruz, Fiocruz</institution>, <addr-line>Rio de Janeiro</addr-line>, <country>Brazil</country></aff>
<author-notes>
<fn id="fn0001" fn-type="edited-by">
<p>Edited by: Santi M. Mandal, Indian Institute of Technology Kharagpur, India</p>
</fn>
<fn id="fn0002" fn-type="edited-by">
<p>Reviewed by: Juan Diego Maya, University of Chile, Chile; William Harold Witola, University of Illinois at Urbana&#x2013;Champaign, United States</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Rafael M. Mariante, <email>rafaelmariante@gmail.com</email>; Rubem F. S. Menna-Barreto, <email>rubemsadok@gmail.com</email></corresp>
<fn id="fn0003" fn-type="other">
<p>This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>29</day>
<month>03</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>856686</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>01</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>03</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2022 Pedra-Rezende, Macedo, Midlej, Mariante and Menna-Barreto.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Pedra-Rezende, Macedo, Midlej, Mariante and Menna-Barreto</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Protozoan parasites interact with a wide variety of organisms ranging from bacteria to humans, representing one of the most common causes of parasitic diseases and an important public health problem affecting hundreds of millions of people worldwide. The current treatment for these parasitic diseases remains unsatisfactory and, in some cases, very limited. Treatment limitations together with the increased resistance of the pathogens represent a challenge for the improvement of the patient&#x2019;s quality of life. The continuous search for alternative preclinical drugs is mandatory, but the mechanisms of action of several of these compounds have not been described. Electron microscopy is a powerful tool for the identification of drug targets in almost all cellular models. Interestingly, ultrastructural analysis showed that several classes of antiparasitic compounds induced similar autophagic phenotypes in trypanosomatids, trichomonadids, and apicomplexan parasites as well as in <italic>Giardia intestinalis</italic> and <italic>Entamoeba</italic> spp. with the presence of an increased number of autophagosomes as well as remarkable endoplasmic reticulum profiles surrounding different organelles. Autophagy is a physiological process of eukaryotes that maintains homeostasis by the self-digestion of nonfunctional organelles and/or macromolecules, limiting redundant and damaged cellular components. Here, we focus on protozoan autophagy to subvert drug effects, discussing its importance for successful chemotherapy.</p>
</abstract>
<kwd-group>
<kwd>protozoa</kwd>
<kwd>drugs</kwd>
<kwd>chemotherapy</kwd>
<kwd>autophagy</kwd>
<kwd>electron microscopy</kwd>
<kwd>endoplasmic reticulum profile</kwd>
<kwd>autophagosome</kwd>
<kwd>myelin-like structure</kwd>
</kwd-group>
<contract-sponsor id="cn1">CNPq<named-content content-type="fundref-id">10.13039/501100003593</named-content></contract-sponsor>
<contract-sponsor id="cn2">CAPES<named-content content-type="fundref-id">10.13039/501100002322</named-content></contract-sponsor>
<contract-sponsor id="cn3">FAPERJ<named-content content-type="fundref-id">10.13039/501100004586</named-content></contract-sponsor>
<contract-sponsor id="cn4">FIOCRUZ<named-content content-type="fundref-id">10.13039/501100006507</named-content></contract-sponsor>
<counts>
<fig-count count="7"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="167"/>
<page-count count="15"/>
<word-count count="11858"/>
</counts>
</article-meta>
</front>
<body>
<sec id="sec1">
<title>Autophagy and Its Molecular Machinery</title>
<p>Autophagy is a physiological process of self-digestion of nonfunctional organelles and/or macromolecules, limiting redundant and damaged cellular components. This biochemical pathway can be selective or nonselective and guarantees eukaryotic homeostasis through the turnover and recycling of target cellular structures, which are pivotal events during cell growth and differentiation (<xref ref-type="bibr" rid="ref103">Menna-Barreto, 2019</xref>; <xref ref-type="bibr" rid="ref1">Abdrakhmanov et al., 2020</xref>; <xref ref-type="bibr" rid="ref78">Klionsky et al., 2021</xref>). Despite nonselective characteristics during different conditions, such as starvation, numerous selective autophagic examples, including mitophagy, reticulophagy, and xenophagy (degradation by autophagy of mitochondria, endoplasmic reticulum, and pathogens, respectively), have been reported (<xref ref-type="bibr" rid="ref1">Abdrakhmanov et al., 2020</xref>).</p>
<p>In pathological situations, including in protozoan infections, autophagy is increased to recover the cellular balance (<xref ref-type="bibr" rid="ref76">Kirkegaard et al., 2004</xref>; <xref ref-type="bibr" rid="ref139">Swanson, 2006</xref>). However, continuous induction of this pathway can culminate in autophagic cell death (<xref ref-type="bibr" rid="ref90">Levine and Yuan, 2005</xref>). In protozoa, the autophagic phenotype is often induced <italic>in vitro</italic> by a great variety of drugs with different well-known mechanisms of action (<xref ref-type="bibr" rid="ref107">Menna-Barreto et al., 2009c</xref>; <xref ref-type="bibr" rid="ref103">Menna-Barreto, 2019</xref>).</p>
<p>Molecularly, autophagy is a highly conserved process regulated by autophagy-related genes (ATGs) previously identified in <italic>Saccharomyces cerevisiae</italic> (<xref ref-type="bibr" rid="ref79">Klionsky et al., 2003</xref>), and their orthologs were subsequently described in all eukaryotes (<xref ref-type="bibr" rid="ref78">Klionsky et al., 2021</xref>). Currently, three autophagic types are presented in the literature: macroautophagy (also called autophagy), microautophagy, and chaperone-mediated autophagy (CMA; <xref ref-type="bibr" rid="ref103">Menna-Barreto, 2019</xref>; <xref ref-type="bibr" rid="ref1">Abdrakhmanov et al., 2020</xref>).</p>
<p>Macroautophagy is characterized by the presence of double membrane organelles named autophagosomes that will address cellular material to be degraded in lysosomes. In a well-controlled process dependent on Atg proteins, a membrane structure (phagophore) surrounds damaged organelles or macromolecules, giving rise to autophagosomes (<xref ref-type="bibr" rid="ref133">Shintani and Klionsky, 2004</xref>; <xref ref-type="bibr" rid="ref3">Alvarez et al., 2008</xref>). The triggering of the process depends on the serine/threonine protein kinase TOR (target of rapamycin), a nutritional availability sensor, and Atg6 (beclin 1 in mammals), which is a phosphatidylinositol 3-kinase (PI-3K; <xref ref-type="bibr" rid="ref50">Duszenko et al., 2011</xref>).</p>
<p>Unlike macroautophagy, autophagosomes are absent in microautophagy. The cellular material that will be degraded is engulfed by invagination of the lysosomal membrane. As demonstrated by electron microscopy, lysosomes full of small vesicles in their lumen are called multivesicular bodies. Unfortunately, this autophagic type is poorly studied due to the absence of specific markers (<xref ref-type="bibr" rid="ref103">Menna-Barreto, 2019</xref>; <xref ref-type="bibr" rid="ref78">Klionsky et al., 2021</xref>).</p>
<p>The most selective autophagic type is CMA, where signal pentapeptides (KFERQ, VDKFQ or QREFK) present in target proteins bind to cytosolic chaperones. The chaperone substrate binds to the lysosomal receptor LAMP-2A, promoting channel formation derived from receptor dimerization. Target molecules are degraded in the lysosomal lumen after entering through this channel (<xref ref-type="bibr" rid="ref50">Duszenko et al., 2011</xref>).</p>
<p>Since the first description more than half a century ago, ultrastructural characterization remains a valuable tool for autophagic phenotype detection, allowing autophagosome identification without the use of specific markers (<xref ref-type="bibr" rid="ref107">Menna-Barreto et al., 2009c</xref>; <xref ref-type="bibr" rid="ref103">Menna-Barreto, 2019</xref>). More recently, knockdown or knockout of autophagic components strategies have also been commonly used. The gold-standard method for monitoring autophagic flux is the detection of Atg8 (LC3 in mammals) by morphological investigation after immunostaining microscopy (presence of LC3 puncta) and/or by immunoblotting (detection of LC3-I and LC3-II; <xref ref-type="bibr" rid="ref78">Klionsky et al., 2021</xref>). In the present work, we reviewed different aspects of the protozoan autophagy exacerbation, discussing the possible role for drug resistance/susceptibility of these pathogens.</p>
</sec>
<sec id="sec2">
<title>Protozoan Diseases and Chemotherapy</title>
<sec id="sec3">
<title>Chagas Disease</title>
<p>Chagas disease, which is caused by the protozoan <italic>Trypanosoma cruzi</italic>, is a neglected illness that affects approximately 6&#x2013;7 million people worldwide, mostly in Latin America, and causes approximately 10,000 deaths per year (<xref ref-type="bibr" rid="ref161">World Health Organization, 2020a</xref>). The occurrence of Chagas disease has also been reported in nonendemic countries, such as Canada, the United States, Australia, and Japan, due to the constant migration of individuals from endemic areas (<xref ref-type="bibr" rid="ref120">Rassi et al., 2010</xref>). The transmission is mainly vectorial, depending on the infected triatomine bug, but <italic>T. cruzi</italic> can also be transmitted through blood transfusion, organ transplantation, ingestion of contaminated food or <italic>via</italic> transplacentary (<xref ref-type="bibr" rid="ref42">Delgado and Gasc&#x00F3;n, 2020</xref>).</p>
<p>Clinically, Chagas disease presents two phases: acute and chronic. In the acute stage, despite patent bloodstream parasitemia, no specific symptoms are detected. In the chronic phase, individuals are asymptomatic in the indeterminate stage; approximately 30%&#x2013;40% of cases progress to the symptomatic stage, which is characterized by cardiac and/or digestive alterations (<xref ref-type="bibr" rid="ref120">Rassi et al., 2010</xref>). The clinical treatment of this disease is still based on the nitrocompounds benznidazole, and nifurtimox, which were discovered half a century ago and are highly effective in acute cases but exhibit limited efficacy in chronic patients (<xref rid="tab1" ref-type="table">Table 1</xref>; <xref ref-type="bibr" rid="ref45">Dias et al., 2016</xref>). Given limitations in currently available treatments, there is an urgent need for alternative and specific treatments. Several efforts have been directed to the development of new drugs or combinations for Chagas disease chemotherapy (<xref ref-type="bibr" rid="ref146">Vannier-Santos et al., 2019</xref>).</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>The main protozoal infections and their current chemotherapies.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Disease</th>
<th align="left" valign="top">Treatment</th>
<th align="left" valign="top">Mechanism of action</th>
<th align="left" valign="top">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="char" valign="top" char=".">Chagas disease</td>
<td align="char" valign="top" char="&#x00B1;">Benznidazole<break/>Nifurtimox</td>
<td align="char" valign="top" char="&#x00B1;">Nitroreductases activation</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref156">Wilkinson et al., 2008</xref></td>
</tr>
<tr>
<td align="char" valign="top" char=".">Sleeping sickness</td>
<td align="char" valign="top" char="&#x00B1;">Suramin</td>
<td align="char" valign="top" char="&#x00B1;">Glycosomal enzymes inhibition</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref8">Babokhov et al., 2013</xref></td>
</tr>
<tr>
<td/>
<td align="char" valign="top" char="&#x00B1;">Pentamidine</td>
<td align="char" valign="top" char="&#x00B1;">Mitochondrial dysfunction</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref151">Vercesi and Docampo, 1992</xref></td>
</tr>
<tr>
<td/>
<td align="char" valign="top" char="&#x00B1;">Eflornithine</td>
<td align="char" valign="top" char="&#x00B1;">Ornithine decarboxylase inhibition</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref95">LoGiudice et al., 2018</xref></td>
</tr>
<tr>
<td/>
<td align="char" valign="top" char="&#x00B1;">Melarsoprol</td>
<td align="char" valign="top" char="&#x00B1;">Trypanothione inhibition</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref72">Kennedy, 2013</xref></td>
</tr>
<tr>
<td align="char" valign="top" char=".">Leishmaniasis</td>
<td align="char" valign="top" char="&#x00B1;">Pentavalent antimonials</td>
<td align="char" valign="top" char="&#x00B1;">Sb (V) to Sb (III) reduction and type I DNA topoisomerases inhibition</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref57">Fr&#x00E9;zard et al., 2009</xref></td>
</tr>
<tr>
<td/>
<td align="char" valign="top" char="&#x00B1;">Amphotericin B</td>
<td align="char" valign="top" char="&#x00B1;">Plasma membrane permeabilization and mitochondrial dysfunction</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref85">Lee et al., 2002</xref></td>
</tr>
<tr>
<td/>
<td align="char" valign="top" char="&#x00B1;">Paromomycin</td>
<td align="char" valign="top" char="&#x00B1;">Protein synthesis inhibition</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref75">Kip et al., 2018</xref></td>
</tr>
<tr>
<td/>
<td align="char" valign="top" char="&#x00B1;">Pentamidine</td>
<td align="char" valign="top" char="&#x00B1;">Mitochondrial dysfunction</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref151">Vercesi and Docampo, 1992</xref></td>
</tr>
<tr>
<td/>
<td align="char" valign="top" char="&#x00B1;">Miltefosine</td>
<td align="char" valign="top" char="&#x00B1;">Cytochrome c oxidase inhibition</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref97">Luque-Ortega and Rivas, 2007</xref></td>
</tr>
<tr>
<td/>
<td align="char" valign="top" char="&#x00B1;">Azolic compounds</td>
<td align="char" valign="top" char="&#x00B1;">CYP51 inhibition</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref52">Emami et al., 2017</xref></td>
</tr>
<tr>
<td align="char" valign="top" char=".">Toxoplasmosis</td>
<td align="char" valign="top" char="&#x00B1;">Pyrimethamine and sulfadiazine</td>
<td align="char" valign="top" char="&#x00B1;">Block the parasite DNA synthesis (by inhibition of the folate metabolic pathway)</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref49">Dunay et al., 2018</xref></td>
</tr>
<tr>
<td/>
<td align="char" valign="top" char="&#x00B1;">Spiramycin</td>
<td align="char" valign="top" char="&#x00B1;">Inhibits translocation (by interference in bacterial 50S ribosomal subunits)</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref22">Brisson-No&#x00EB;l et al., 1988</xref>; <xref ref-type="bibr" rid="ref23">Brook, 1998</xref></td>
</tr>
<tr>
<td align="char" valign="top" char=".">Malaria</td>
<td align="char" valign="top" char="&#x00B1;">Chloroquine</td>
<td align="char" valign="top" char="&#x00B1;">Intravacuolar pH increasing (hemoglobin digestion interfered)</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref58">Gabay et al., 1994</xref></td>
</tr>
<tr>
<td/>
<td align="char" valign="top" char="&#x00B1;">Hydroxychloroquine</td>
<td align="char" valign="top" char="&#x00B1;">Intravacuolar pH increasing (hemoglobin digestion interfered)</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref56">Fox, 1993</xref></td>
</tr>
<tr>
<td/>
<td align="char" valign="top" char="&#x00B1;">Artemether-lumefantrine</td>
<td align="char" valign="top" char="&#x00B1;">Free radical damage to parasite organelles and proteins.</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref155">White et al., 1999</xref></td>
</tr>
<tr>
<td/>
<td align="char" valign="top" char="&#x00B1;">Atovaquone-proguanil</td>
<td align="char" valign="top" char="&#x00B1;">Mitochondrial electron transport inhibition</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref113">Painter et al., 2010</xref>; <xref ref-type="bibr" rid="ref143">Vaidya, 2011</xref></td>
</tr>
<tr>
<td/>
<td align="char" valign="top" char="&#x00B1;">Doxycycline</td>
<td align="char" valign="top" char="&#x00B1;">Inhibits apicoplast protein translation (organelle dysfunction)</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref21">Briolant et al., 2010</xref></td>
</tr>
<tr>
<td/>
<td align="char" valign="top" char="&#x00B1;">Tetracycline</td>
<td align="char" valign="top" char="&#x00B1;">Protein synthesis inhibition (results in nonfunctional apicoplasts)</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref39">Dahl et al., 2006</xref></td>
</tr>
<tr>
<td/>
<td align="char" valign="top" char="&#x00B1;">Clindamycin</td>
<td align="char" valign="top" char="&#x00B1;">Protein synthesis inhibition (results in nonfunctional apicoplasts)</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref39">Dahl et al., 2006</xref></td>
</tr>
<tr>
<td/>
<td align="char" valign="top" char="&#x00B1;">Mefloquine</td>
<td align="char" valign="top" char="&#x00B1;">Intravacuolar pH increasing (hemoglobin digestion blockage)</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref109">Mungthin et al., 1998</xref></td>
</tr>
<tr>
<td/>
<td align="char" valign="top" char="&#x00B1;">Artesunate</td>
<td align="char" valign="top" char="&#x00B1;">Parasite DNA damage</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref63">Gopalakrishnan and Kumar, 2015</xref></td>
</tr>
<tr>
<td align="char" valign="top" char=".">Giardiasis Trichomoniasis and Amebiasis</td>
<td align="char" valign="top" char="&#x00B1;">Nitroimidazoles</td>
<td align="char" valign="top" char="&#x00B1;">Damage DNA and proteins</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref94">Lindmark and M&#x00FC;ller, 1976</xref>; <xref ref-type="bibr" rid="ref86">Leitsch et al., 2012</xref>; <xref ref-type="bibr" rid="ref108">Muller et al., 2015</xref>;</td>
</tr>
<tr>
<td/>
<td align="char" valign="top" char="&#x00B1;">Benzimidazoles</td>
<td align="char" valign="top" char="&#x00B1;">Blocking glucose uptake and inhibit microtubules polymerization</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref128">Sears and O&#x2019;Hare, 1988</xref></td>
</tr>
<tr>
<td/>
<td align="char" valign="top" char="&#x00B1;">Nitazoxanide</td>
<td align="char" valign="top" char="&#x00B1;">Inhibition of enzymes that participates in energy conversion and possibly production of nitro radicals</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref69">Hoffman et al., 2007</xref></td>
</tr>
<tr>
<td/>
<td align="char" valign="top" char="&#x00B1;">Paromomycin</td>
<td align="char" valign="top" char="&#x00B1;">Inhibition of protein synthesis</td>
<td align="char" valign="top" char="&#x00B1;"><xref ref-type="bibr" rid="ref51">Edlind, 1989</xref></td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec4">
<title>Sleeping Sickness</title>
<p>Caused by <italic>Trypanosoma brucei</italic>, sleeping sickness is a neglected disease transmitted by tsetse flies (<italic>Glossina</italic> genus) that occurs exclusively in sub-Saharan Africa with rural populations being more exposed to the vector (<xref ref-type="bibr" rid="ref28">Centers for Disease Control and Prevention, 2019</xref>). At present, approximately 70 million people are at risk of infection, and 30,000 new cases are emerging regardless of disease control initiatives (<xref ref-type="bibr" rid="ref163">World Health Organization, 2022</xref>). There are two subspecies that are pathogenic to humans: <italic>T. brucei gambiense</italic> and <italic>T. brucei rhodesiense</italic>. The most prevalent is <italic>T. brucei gambiense</italic>, which is present in western Africa and causes approximately 98% of reported cases, whereas <italic>T. brucei rhodesiense</italic> is found in eastern Africa and is much less prevalent (<xref ref-type="bibr" rid="ref28">Centers for Disease Control and Prevention, 2019</xref>). Alternative routes of transmission have also been reported, such as transplacentary or mechanical transmission through other blood-sucking insects, but both are less frequent than the classical tsetse route (<xref ref-type="bibr" rid="ref47">Drugs for Neglected Diseases Initiative, 2020</xref>).</p>
<p>Sleeping sickness presents in two distinct clinical phases depending on the localization of the parasite. In the first stage, <italic>T. brucei</italic> is mainly localized in the host bloodstream. However, in the second phase, the parasite is concentrated in the central nervous system, causing progressive neurological injury (<xref ref-type="bibr" rid="ref72">Kennedy, 2013</xref>). The current treatment of the disease varies depending on the infectious species (<italic>T. brucei gambiense</italic> or <italic>T. brucei rhodesiense</italic>) as well as the disease phase (early or late stage). Pentamidine is the first choice for early stage <italic>T. brucei gambiense</italic> infection, while suramin is recommended for the early stage of <italic>T. brucei rhodesiense</italic> infection (<xref rid="tab1" ref-type="table">Table 1</xref>; <xref ref-type="bibr" rid="ref73">Kennedy and Rodgers, 2019</xref>). For the late stage, melarsoprol and eflornithine represent the primary treatment options, and the latter is generally used in association with nifurtimox. Fexinidazole is an oral treatment indicated as the first line for the first stage and nonsevere second stage in <italic>T. brucei gambiense</italic> (<xref ref-type="bibr" rid="ref163">World Health Organization, 2022</xref>). The high toxicity of clinical drugs, especially melarsoprol, encourages the search for alternatives for anti-<italic>T. brucei</italic> chemotherapy.</p>
</sec>
<sec id="sec5">
<title>Leishmaniasis</title>
<p>Leishmaniasis is another neglected disease caused by 20 different <italic>Leishmania</italic> species that are spread by phlebotomine sandflies (<xref ref-type="bibr" rid="ref27">Centers for Disease Control and Prevention, 2021a</xref>). Globally, more than 12 million people worldwide are infected, and 350 million people are at risk of infection with approximately 1.6 million new cases and 20,000&#x2013;30,000 deaths each year (<xref ref-type="bibr" rid="ref114">Pan American Health Organization, 2019</xref>). Distinct species of <italic>Leishmania</italic> spp. cause different clinical manifestations, and there are three different forms of the disease: mucosal, cutaneous, and visceral (kala-azar; <xref ref-type="bibr" rid="ref27">Centers for Disease Control and Prevention, 2021a</xref>).</p>
<p>Due to the complexity of clinical manifestations and the diversity of etiological agent species, there are still many difficulties in finding a unique and effective treatment (<xref ref-type="bibr" rid="ref71">Kaye and Scott, 2011</xref>). Pentavalent antimonial compounds constitute the first-line treatment, and meglumine antimoniate and sodium stibogluconate are the two main formulations. Other drugs, such as amphotericin B, paromomycin, pentamidine, miltefosine, and azolic compounds, are also commonly used alone or in combination (<xref rid="tab1" ref-type="table">Table 1</xref>; <xref ref-type="bibr" rid="ref7">Aronson et al., 2016</xref>). Undesirable side effects together with reports of resistance to conventional drugs justify the continuous search for new leishmanicidal agents (<xref ref-type="bibr" rid="ref40">De Menezes et al., 2015</xref>). Among the novel approaches for cutaneous leishmaniasis, CO<sub>2</sub> laser administration and thermotherapy, cryotherapy, electrotherapy, intralesional administration, combination therapy, immunomodulation, nanotechnology, and drug repurposing have been employed (<xref ref-type="bibr" rid="ref122">Roatt et al., 2020</xref>).</p>
</sec>
<sec id="sec6">
<title>Toxoplasmosis</title>
<p>Toxoplasmosis is a disease caused by the obligate intracellular protozoan <italic>Toxoplasma gondii</italic>. This is the most prevalent infectious disease in humans, chronically infecting approximately one-third of the world&#x2019;s population (<xref ref-type="bibr" rid="ref48">Dubey, 2010</xref>). The successful worldwide distribution of <italic>T. gondii</italic> is attributed to the high diversity of host species it can infect, including almost all warm-blooded animals, and its multiple mechanisms of transmission, which include ingestion by the host of undercooked meat containing parasite cysts or oocyst-contaminated food or water (<xref ref-type="bibr" rid="ref49">Dunay et al., 2018</xref>; <xref ref-type="bibr" rid="ref29">Centers for Disease Control and Prevention, 2021b</xref>). Due to the infrequent or mild clinical manifestations, toxoplasmosis is considered an opportunistic infection in immunosuppressed patients and pregnant women, leading to severe symptoms, such as retinochoroiditis and mental disability (<xref ref-type="bibr" rid="ref29">Centers for Disease Control and Prevention, 2021b</xref>).</p>
<p>Treatment of toxoplasmosis typically involves a combination of antimicrobials, such as pyrimethamine and sulfadiazine, plus folinic acid depending on the disease presentation, and particularities are noted in pregnant women (<xref rid="tab1" ref-type="table">Table 1</xref>; <xref ref-type="bibr" rid="ref49">Dunay et al., 2018</xref>; <xref ref-type="bibr" rid="ref29">Centers for Disease Control and Prevention, 2021b</xref>). Unfortunately, the drugs used in clinical practice are only active against tachyzoites, the replicative form of the parasite, and do not demonstrate activity against tissue cysts containing bradyzoites, a latent stage of <italic>T. gondii</italic> that is present in the chronic phase of the disease (<xref ref-type="bibr" rid="ref49">Dunay et al., 2018</xref>).</p>
</sec>
<sec id="sec7">
<title>Malaria</title>
<p><italic>Plasmodium</italic> is the causative agent of malaria, a disease transmitted by the <italic>Anopheles</italic> mosquito, affecting tropical and subtropical countries, especially in Africa (<xref ref-type="bibr" rid="ref37">Cowman et al., 2016</xref>; <xref ref-type="bibr" rid="ref30">Centers for Disease Control and Prevention, 2021c</xref>). In 2019, malaria led to more than 400,000 deaths worldwide, mainly affecting children due to underdeveloped immunity. Thus, the disease is noted as one of the most serious and deadly illnesses in the world (<xref ref-type="bibr" rid="ref102">Mbacham et al., 2019</xref>; <xref ref-type="bibr" rid="ref162">World Health Organization, 2020b</xref>). Due to efficient public health strategies, an important reduction in cases can be observed in developed countries, and new cases are typically associated with immigrants and tourists from endemic areas (<xref ref-type="bibr" rid="ref36">Cotter et al., 2013</xref>; <xref ref-type="bibr" rid="ref59">Gachelin et al., 2018</xref>). Regarding clinical manifestations, malaria presents milder to more specific symptoms according to disease progression, including organ failure, blood abnormalities, cerebral malaria, and even death if not treated (<xref ref-type="bibr" rid="ref30">Centers for Disease Control and Prevention, 2021c</xref>).</p>
<p>Treatment varies with the severity of the disease and the <italic>Plasmodium</italic> species, among other factors (<xref ref-type="bibr" rid="ref154">White, 1996</xref>). Antimalarial drugs, such as chloroquine and hydroxychloroquine, have been the most widely administered to patients with uncomplicated malaria since their development. However, due to drug resistance over time, the disease can now be effectively treated with other drugs, such as artemether-lumefantrine (<xref rid="tab1" ref-type="table">Table 1</xref>). For severe malaria, the patient should be treated with intravenous artesunate (<xref ref-type="bibr" rid="ref145">Van Vugt et al., 2011</xref>; <xref ref-type="bibr" rid="ref30">Centers for Disease Control and Prevention, 2021c</xref>).</p>
</sec>
<sec id="sec8">
<title>Giardiasis</title>
<p><italic>Giardia intestinalis</italic> (syn. <italic>Giardia lamblia</italic>, <italic>Giardia duodenalis</italic>) is the most common parasite related to gastrointestinal infections in the world, affecting approximately 200 million people annually (<xref ref-type="bibr" rid="ref32">Certad et al., 2017</xref>). Most cases are characterized by asymptomatic infections. However, these infections will release infectious cysts, perpetuating parasite dissemination (<xref ref-type="bibr" rid="ref25">Capewell et al., 2021</xref>). The main symptoms of giardiasis are diarrhea and weight loss, which are linked to trophozoite adhesion to host intestinal epithelia, inefficient nutrient and water uptake, and triggering of an immune response (<xref ref-type="bibr" rid="ref87">Leung et al., 2019</xref>). In some cases, giardiasis leads to a loss of barrier function and dysbiosis of the gut flora, presenting features similar to irritable bowel syndrome (<xref ref-type="bibr" rid="ref2">Allain and Buret, 2020</xref>). The clinical effects of giardiasis are more significant in children, in which psychomotor and cognitive development can also be adversely affected during the infection, beyond the classical symptoms (<xref ref-type="bibr" rid="ref123">Rogawski et al., 2017</xref>).</p>
<p>The current treatment of giardiasis is based on several drug classes. 5-Nitroimidazole derivatives are the most prescribed compounds, and metronidazole (MTZ) is often the drug of choice (<xref rid="tab1" ref-type="table">Table 1</xref>). Among the other alternatives used, albendazole and mebendazole also stand out (<xref ref-type="bibr" rid="ref53">Escobedo et al., 2016</xref>). MTZ presents undesirable side effects, usually resulting in treatment interruption. Drug resistance has been reported both <italic>in vitro</italic> and <italic>in vivo</italic>, and a complete parasitological cure has not been achieved (<xref ref-type="bibr" rid="ref6">Arg&#x00FC;ello-Garc&#x00ED;a et al., 2020</xref>).</p>
</sec>
<sec id="sec9">
<title>Trichomoniasis</title>
<p>Despite the advances achieved from public campaigns carried out in recent decades, sexually transmitted infections (STIs) and their consequences are among the top five reasons that cause people in developing countries to seek medical treatment (<xref ref-type="bibr" rid="ref38">Cudmore and Garber, 2010</xref>). Human trichomoniasis caused by the protozoan <italic>Trichomonas vaginalis</italic> is an STI with a wide geographic distribution that affects approximately 156 million people worldwide (<xref ref-type="bibr" rid="ref124">Rowley et al., 2019</xref>). This disease is characterized by an infection of the urogenital tract and is more frequently noted in females. Severe and irritating inflammation resulting from exacerbated vaginal leukorrhea is the main pathological consequence (<xref ref-type="bibr" rid="ref38">Cudmore and Garber, 2010</xref>; <xref ref-type="bibr" rid="ref129">Secor, 2012</xref>). In men, trichomoniasis is typically asymptomatic, and the host acts only as a carrier. However, trichomoniasis can sporadically cause urethritis, prostatitis, and infertility (<xref ref-type="bibr" rid="ref129">Secor, 2012</xref>). The greater predisposition of infected individuals to viral, bacterial, and fungal infections as well as the association between the presence of the parasite and a higher incidence of cervical cancer and an aggressive type of prostate cancer underscore the importance of trichomoniasis in human medicine (<xref ref-type="bibr" rid="ref68">Hirt, 2013</xref>).</p>
<p>Trichomoniasis is only treated in women, and treatment is mainly based on MTZ administration (<xref rid="tab1" ref-type="table">Table 1</xref>; <xref ref-type="bibr" rid="ref144">Van Gerwen and Muzny, 2019</xref>). In addition to MTZ, tinidazole (TIN) is also prescribed due to better absorption and fewer gastrointestinal side effects than MTZ (<xref ref-type="bibr" rid="ref153">Viitanen et al., 1985</xref>). Other drugs, such as disulfiram and nithiamide, can be used when patients have hypersensitivity to 5-nitroimidazoles (<xref ref-type="bibr" rid="ref128">Sears and O&#x2019;Hare, 1988</xref>).</p>
</sec>
<sec id="sec10">
<title>Amebiasis</title>
<p>Amebiasis is an enteric infection quite similar to giardiasis with one important difference: its disease state can range from intestinal inflammation to a severe liver abscess (<xref ref-type="bibr" rid="ref134">Shirley et al., 2018</xref>). In humans, the disease is mainly caused by the nonflagellated protozoa <italic>Entamoeba histolytica</italic> (<xref ref-type="bibr" rid="ref132">Shimokawa et al., 2012</xref>). Amebic infection is one of the main causes of diarrhea worldwide, mainly in young children. In developing countries, childhood diarrhea is a very common cause of death, accounting for approximately 9% of deaths in children under 5&#x2009;years old (<xref ref-type="bibr" rid="ref141">United Nations International Children&#x2019;s Emergency Fund, 2018</xref>).</p>
<p>The most effective treatment for amebiasis is based on the administration of MTZ, mainly for the invasive disease form (<xref ref-type="bibr" rid="ref54">Farthing, 2006</xref>). Paramomycin and diloxanide furoate are luminal agents commonly used to eliminate cysts from the colon (<xref ref-type="bibr" rid="ref166">Zulfiqar et al., 2021</xref>). Other nitroimidazole derivatives, including tinidazole and ornidazole, are also used (<xref rid="tab1" ref-type="table">Table 1</xref>; <xref ref-type="bibr" rid="ref33">Chac&#x00ED;n-Bonilla, 2013</xref>). The severe complication of amebiasis, namely, liver abscess, can be managed through aspiration using computed tomography as a guide combined with MTZ. In some cases, surgery is also required to treat gastrointestinal bleeding, megacolon, liver abscesses, and other severe damages when drainage is not possible (<xref ref-type="bibr" rid="ref62">Gonz&#x00E1;lez-Alcaide et al., 2017</xref>).</p>
</sec>
</sec>
<sec id="sec11">
<title>Autophagy in Protozoa</title>
<p>In protozoa, autophagy was first reported in <italic>T. brucei</italic> in 1977 by <xref ref-type="bibr" rid="ref152">Vickerman and Tetley (1977)</xref> based on ultrastructural evidence. To date, parasites under starvation and/or subjected to other stress conditions commonly present autophagic features, including an increase in autophagosome number, multivesicular bodies, and myelin-like structures (<xref rid="fig1" ref-type="fig">Figures 1A</xref>&#x2013;<xref rid="fig1" ref-type="fig">D</xref>, <xref rid="fig2" ref-type="fig">2A&#x2013;F</xref>, <xref rid="fig3" ref-type="fig">3A,B</xref>; <xref ref-type="bibr" rid="ref11">Benchimol, 1999</xref>; <xref ref-type="bibr" rid="ref99">Maia et al., 2007</xref>; <xref ref-type="bibr" rid="ref35">Corr&#x00EA;a et al., 2009</xref>; <xref ref-type="bibr" rid="ref107">Menna-Barreto et al., 2009c</xref>; <xref ref-type="bibr" rid="ref14">Besteiro et al., 2011</xref>; <xref ref-type="bibr" rid="ref61">Ghosh et al., 2012</xref>; <xref ref-type="bibr" rid="ref80">Koh et al., 2015</xref>; <xref ref-type="bibr" rid="ref118">Picazarri et al., 2015</xref>; <xref ref-type="bibr" rid="ref138">Souto et al., 2016</xref>; <xref ref-type="bibr" rid="ref111">Nguyen et al., 2017b</xref>; <xref ref-type="bibr" rid="ref67">Hern&#x00E1;ndez-Garc&#x00ED;a et al., 2019</xref>; <xref ref-type="bibr" rid="ref5">Araujo-Silva et al., 2021</xref>; <xref ref-type="bibr" rid="ref164">Wu et al., 2021</xref>; <xref ref-type="bibr" rid="ref165">Zhang et al., 2021</xref>). Interestingly, concentric membrane and myelin-like structures share morphological similarities to the phagophore described in yeast and mammals. The endoplasmic reticulum (ER), the main source of the phagophoric membrane, is frequently found surrounding degraded subcellular structures, especially in stressed parasites (<xref rid="fig3" ref-type="fig">Figures 3A</xref>,<xref rid="fig3" ref-type="fig">B</xref>; <xref ref-type="bibr" rid="ref99">Maia et al., 2007</xref>; <xref ref-type="bibr" rid="ref35">Corr&#x00EA;a et al., 2009</xref>; <xref ref-type="bibr" rid="ref101">Martins-Duarte et al., 2009</xref>; <xref ref-type="bibr" rid="ref104">Menna-Barreto et al., 2009a</xref>; <xref ref-type="bibr" rid="ref50">Duszenko et al., 2011</xref>; <xref ref-type="bibr" rid="ref24">Busatti et al., 2013</xref>; <xref ref-type="bibr" rid="ref67">Hern&#x00E1;ndez-Garc&#x00ED;a et al., 2019</xref>).</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Transmission electron microscopy analysis of autophagy in pathogenic protozoa. <bold>(A,B)</bold> <italic>Trypanosoma cruzi</italic>. <bold>(C,D)</bold> <italic>Trichomonas vaginalis</italic>. <bold>(A&#x2013;D)</bold> Under autophagic stimuli (drugs, starvation among others), parasites present a high number of autophagosomes (stars) distributed all over the cell. N, nucleus; M, mitochondrion; F, flagella; H, hydrogenosome; and ER, endoplasmic reticulum. Bars&#x2009;=&#x2009;0.5&#x2009;&#x03BC;m.</p>
</caption>
<graphic xlink:href="fmicb-13-856686-g001.tif"/>
</fig>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Transmission electron microscopy analysis of autophagosomes in pathogenic protozoa. <bold>(A&#x2013;C,E)</bold> <italic>Trypanosoma cruzi</italic>. <bold>(D,F)</bold> <italic>Trichomonas vaginalis</italic>. <bold>(A&#x2013;D)</bold> Autophagosomes with cargo in different levels of degradation (stars). Small vesicles in close contact with autophagosomal membrane were also observed (arrows). <bold>(E,F)</bold> Multivesicular bodies (asterisks). H, hydrogenosome. Bars&#x2009;=&#x2009;0.5&#x2009;&#x03BC;m.</p>
</caption>
<graphic xlink:href="fmicb-13-856686-g002.tif"/>
</fig>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Transmission electron microscopy analysis of ER surrounding organelles in <italic>Trypanosoma cruzi</italic>. <bold>(A,B)</bold> Endoplasmic reticulum (ER) profiles is recurrently observed in close contact with a great variety of organelles (arrows) in treated parasites. The treatment with drugs also induces the appearance of concentric membrane structures (i.e., myelin-like structures) and the formation of autophagosomes (star). M, mitochondrion; N, nucleus; G, Golgi; and R, reservosome. Bars&#x2009;=&#x2009;0.5&#x2009;&#x03BC;m.</p>
</caption>
<graphic xlink:href="fmicb-13-856686-g003.tif"/>
</fig>
<p>Regarding the molecular machinery, the autophagic pathway is well conserved among eukaryotes. Many ATG homologs have been identified in pathogenic protozoa, but some components are lacking or differ from those found in yeast. In trypanosomatids, genes involved in phagophore elongation and degradation of autophagosome cargo were detected by <italic>in silico</italic> approaches, including the complete Atg8 conjugation system (Atg3, Atg4, Atg7, and Atg8; <xref rid="fig4" ref-type="fig">Figure 4</xref>; <xref ref-type="bibr" rid="ref65">Herman et al., 2006</xref>). Similar data were obtained in <italic>Entamoeba</italic> and <italic>T. vaginalis</italic>, where the Atg8 conjugation system was described, and the Atg12 complex is lacking (<xref ref-type="bibr" rid="ref118">Picazarri et al., 2015</xref>; <xref ref-type="bibr" rid="ref67">Hernand&#x00E9;z-Garc&#x00ED;a et al., 2019</xref>; <xref ref-type="bibr" rid="ref70">Huang et al., 2019</xref>). In <italic>Giardia</italic>, bioinformatic analysis revealed the TOR, S6K1, PI3K, Atg1, Atg16, Atg7, Atg8, and Atg18 genes (<xref ref-type="bibr" rid="ref31">Cernikova et al., 2020</xref>; <xref ref-type="bibr" rid="ref164">Wu et al., 2021</xref>). <italic>Toxoplasma gondii</italic> seems to have well-conserved autophagic machinery, presenting several putative orthologs of yeast Atgs, including proteins of the Atg1, TOR, and PI3K complexes and Atg9 and Atg8/Atg12 systems (<xref ref-type="bibr" rid="ref89">L&#x00E9;v&#x00EA;que and Besteiro, 2016</xref>; <xref ref-type="bibr" rid="ref13">Besteiro, 2017</xref>). On the other hand, the Atg repertoire in <italic>Plasmodium</italic> did not reveal the presence of Atg24, TOR kinase, Atg9, Atg6, and Atg16, but the other Atgs found in <italic>T. gondii</italic> are also present (<xref ref-type="bibr" rid="ref89">L&#x00E9;v&#x00EA;que and Besteiro, 2016</xref>; <xref ref-type="bibr" rid="ref13">Besteiro, 2017</xref>).</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>Atg8 detection is the gold standard method for monitoring autophagy. Rabbit anti-TcAtg8 antibody was employed to reveal Atg8 puncta (arrowheads) in <italic>Trypanosoma cruzi</italic> epimastigotes. Secondary antibody: anti-rabbit Alexa 488. Bar&#x2009;=&#x2009;10&#x2009;&#x03BC;m.</p>
</caption>
<graphic xlink:href="fmicb-13-856686-g004.tif"/>
</fig>
<p>The first functional analysis of Atgs in protozoa was performed in <italic>L. major</italic> in 2006 (<xref ref-type="bibr" rid="ref15">Besteiro et al., 2006</xref>). The role of Atg8 and Atg4 was assessed in <italic>T. cruzi</italic> in 2008, and its activity was found to be directly related to the differentiation process of the parasite. The isoforms of Atg8 (TcAtg8.1 and TcAtg8.2) and Atg4 (Atg4.1 and Atg4.2) were investigated, showing the localization of Atg8.1 in autophagosomes of parasites under nutritional deprivation (<xref ref-type="bibr" rid="ref3">Alvarez et al., 2008</xref>). Other Atg8 isoforms were identified in <italic>Leishmania</italic> spp. and <italic>T. brucei</italic> (Atg8, Atg8A, Atg8B, and Atg8C) and are regulated by the same two Atg4 isoforms (<xref ref-type="bibr" rid="ref121">Rigden et al., 2005</xref>; <xref ref-type="bibr" rid="ref82">Koopmann et al., 2009</xref>; <xref ref-type="bibr" rid="ref159">Williams et al., 2009</xref>). On the other hand, in trypanosomatids, the Atg12 conjugation system is incomplete, and ATG5, ATG10, and ATG12 are lacking (<xref ref-type="bibr" rid="ref65">Herman et al., 2006</xref>; <xref ref-type="bibr" rid="ref74">Kiel, 2010</xref>). In <italic>E. histolytica</italic>, no Atg regulation was described during starvation, but EhAtg8 has a function in driving phagosome acidification (<xref ref-type="bibr" rid="ref118">Picazarri et al., 2015</xref>). Atg8 is upregulated during the <italic>G. intestinalis</italic> differentiation process, and its expression induces parasite encystation (<xref ref-type="bibr" rid="ref164">Wu et al., 2021</xref>). Moreover, <italic>T. vaginalis</italic> expresses two Atg8 genes, TvAtg8a and TvAtg8b, both of which retain a functional domain of Atg8. Moreover, TvAtg8a is more highly expressed (<xref ref-type="bibr" rid="ref70">Huang et al., 2019</xref>).</p>
<p>The presence of genes encoding TOR kinases (TOR1 and TOR2) and their respective complexes (TORC1 and TORC2) was also detected in pathogenic trypanosomatids; however, their functions were not fully investigated. Following treatment with rapamycin, a classical autophagic inducer, an increased number of autophagosomes derived from TORC2 inhibition in <italic>T. brucei</italic> were observed, blocking parasite replication (<xref ref-type="bibr" rid="ref10">Barquilla et al., 2008</xref>; <xref ref-type="bibr" rid="ref43">Denninger et al., 2008</xref>). In <italic>Giardia</italic> and <italic>Trichomonas</italic>, rapamycin increased the number of Atg8 puncta, which may regulate parasite growth and differentiation into cysts (<xref ref-type="bibr" rid="ref67">Hernand&#x00E9;z-Garc&#x00ED;a et al., 2019</xref>; <xref ref-type="bibr" rid="ref164">Wu et al., 2021</xref>). A putative ortholog of mammalian TOR kinase is present in the <italic>T. gondii</italic> genome (TgTOR, TGME49_116440). To assess whether TgTOR is a component of the amino acid sensing mechanism, the parasites were treated with rapamycin, mimicking amino acid deprivation. Increasing drug concentrations induced a dose-dependent accumulation of Atg8 puncta, suggesting an increase in autophagic activity in the parasites (<xref ref-type="bibr" rid="ref14">Besteiro et al., 2011</xref>) and a dose-dependent fragmentation of the parasite&#x2019;s mitochondria (<xref ref-type="bibr" rid="ref61">Ghosh et al., 2012</xref>).</p>
<p>As previously mentioned, autophagy seems to be particularly important for the success of the protozoan life cycle, especially during the differentiation steps (<xref ref-type="bibr" rid="ref3">Alvarez et al., 2008</xref>; <xref ref-type="bibr" rid="ref14">Besteiro et al., 2011</xref>; <xref ref-type="bibr" rid="ref88">L&#x00E9;v&#x00EA;que et al., 2015</xref>; <xref ref-type="bibr" rid="ref118">Picazarri et al., 2015</xref>; <xref ref-type="bibr" rid="ref137">Smith et al., 2021</xref>; <xref ref-type="bibr" rid="ref164">Wu et al., 2021</xref>). <italic>Trypanosoma cruzi</italic> epimastigotes are submitted to limited nutrients after their migration to the triatominae rectum, a crucial step for the occurrence of metacyclogenesis (<xref ref-type="bibr" rid="ref3">Alvarez et al., 2008</xref>; <xref ref-type="bibr" rid="ref50">Duszenko et al., 2011</xref>). Recently, <xref ref-type="bibr" rid="ref96">Losinno et al. (2021)</xref> described the involvement of acidocalcisomes during this differentiation process. Autophagic vesicles released from this organelle fuse to reservosomes, contributing to reservosomal acidification and consequently increasing the hydrolytic activity of the cysteine protease cruzipain, resulting in parasite self-proteolysis (<xref ref-type="bibr" rid="ref96">Losinno et al., 2021</xref>). Further experiments on the role of this self-processing and cruzipain activation in parasite differentiation and infection in both invertebrate and vertebrate hosts must be performed. In <italic>Leishmania</italic> spp., metacyclogenesis is also regulated by autophagy (<xref ref-type="bibr" rid="ref15">Besteiro et al., 2006</xref>; <xref ref-type="bibr" rid="ref157">Williams et al., 2006</xref>). Atg4.2 deletion blocked autophagic flux, leading to the accumulation of lipidated Atg8 and a decrease in the percentage of promastigotes under differentiation (<xref ref-type="bibr" rid="ref126">Schoijet et al., 2017</xref>) as well as during <italic>L. mexicana</italic> amastigogenesis (<xref ref-type="bibr" rid="ref157">Williams et al., 2006</xref>). In this parasite, megasomes are lysosome-like organelles that play a crucial role during the differentiation process. The deletion of two megasomal cysteine peptidases (CPA and CPB) also led to the impairment of amastigogenesis, and a high number of autophagosomes were found in mutant parasites (<xref ref-type="bibr" rid="ref157">Williams et al., 2006</xref>; <xref ref-type="bibr" rid="ref74">Kiel, 2010</xref>). At least for trypanosomatids, the involvement of autophagy in the regulation of virulence and infectivity in vertebrate hosts is clear (<xref ref-type="bibr" rid="ref15">Besteiro et al., 2006</xref>), but the related molecular processes still need to be elucidated.</p>
<p>Due to the remarkable differences among vertebrate and invertebrate hosts, it is common sense that nutrient availability, temperature, and pH, among other environmental conditions influence protozoan metabolism, including ATP production (<xref ref-type="bibr" rid="ref74">Kiel, 2010</xref>). Interestingly, the regulation of some of these metabolic adaptations occurs by autophagy. <xref ref-type="bibr" rid="ref91">Li and He (2014</xref>, <xref ref-type="bibr" rid="ref92">2017)</xref> showed that autophagic flux participates in acidocalcisome acidification and that the blockage of organelle biogenesis also impairs the autophagic pathway in <italic>T. brucei</italic>. In <italic>G. intestinalis</italic>, Atg8 interacts with other proteins, such as myeloid leukemia factor (MLF) and FYVE domains, participating in the protein metabolism pathway and processing mitosomal and encystation proteins (<xref ref-type="bibr" rid="ref164">Wu et al., 2021</xref>). In <italic>Entamoeba</italic>, <italic>Eh</italic>Atg8 is involved in the incorporation, scavenging and intracellular trafficking of nutrients (<xref ref-type="bibr" rid="ref118">Picazarri et al., 2015</xref>). On the other hand, glucose restriction in <italic>T. vaginalis</italic> induces autophagy associated with TvAtg8 expression and autophagosome-like formation (<xref ref-type="bibr" rid="ref70">Huang et al., 2019</xref>).</p>
<p>In apicomplexan parasites, Atg8 exerts unique functions. In addition to its cytosolic or, in the case of stressful conditions, vesicular location, it also localizes to the apicoplasts of <italic>Toxoplasma</italic> and <italic>Plasmodium</italic> (<xref ref-type="bibr" rid="ref77">Kitamura et al., 2012</xref>; <xref ref-type="bibr" rid="ref81">Kong-Hap et al., 2013</xref>; <xref ref-type="bibr" rid="ref140">Tomlins et al., 2013</xref>; <xref ref-type="bibr" rid="ref88">L&#x00E9;v&#x00EA;que et al., 2015</xref>). In <italic>T. gondii</italic>, Atg8 is responsible for the proper segregation of the organelle by tethering it to the centrosomes during the replication of the parasite (<xref ref-type="bibr" rid="ref88">L&#x00E9;v&#x00EA;que et al., 2015</xref>). In <italic>Plasmodium</italic>, the protein contributes to apicoplast formation and maintenance (<xref ref-type="bibr" rid="ref140">Tomlins et al., 2013</xref>). Given that the apicoplast is important for the synthesis of isoprenoid precursors and fatty acids, which are essential for parasite survival (<xref ref-type="bibr" rid="ref131">Sheiner et al., 2013</xref>), Atg8 has an indirect but important role in apicomplexan metabolism.</p>
<p>Autophagy is also involved in the control of mitochondrial functionality and phospholipid homeostasis in protozoa (<xref ref-type="bibr" rid="ref15">Besteiro et al., 2006</xref>; <xref ref-type="bibr" rid="ref158">Williams et al., 2012</xref>; <xref ref-type="bibr" rid="ref148">Vanrell et al., 2017</xref>). <italic>Trypanosoma cruzi</italic> epimastigotes submitted to an acidic environment or nutritional deprivation showed intense autophagic activity, ROS generation, and mitochondrial remodeling. These conditions reproduce the triatomine rectum environment, which is crucial for differentiation to the metacyclic form, suggesting a direct correlation between autophagy and mitochondrial remodeling during the process. On the other hand, insect blood digestion promotes transitory alkaline conditions. Our group also demonstrated that alkaline medium led to early exacerbation of autophagy and mitochondrial impairment. These features recovered over time, indicating a survival mechanism to increase the autophagic flux for the removal of damaged structures (<xref ref-type="bibr" rid="ref116">Pedra-Rezende et al., 2021</xref>). <italic>Leishmania major</italic> promastigotes deficient in Atg5, which are not capable of forming autophagosomes, also presented a remarkable decrease in their virulence <italic>in vitro</italic> and <italic>in vivo</italic>. Strong mitochondrial dysfunction was also observed in these mutants together with the increased phosphatidylethanolamine (PE) content and ROS production, suggesting a conjugation of mitochondrial PE to Atg8 for autophagosome biogenesis (<xref ref-type="bibr" rid="ref158">Williams et al., 2012</xref>). In <italic>T. gondii</italic>, starvation leads to mitochondrial dysfunction with consequent impairment of host cell invasion capacity and accumulation of Atg8 puncta (<xref ref-type="bibr" rid="ref14">Besteiro et al., 2011</xref>; <xref ref-type="bibr" rid="ref61">Ghosh et al., 2012</xref>). The use of mutated and conditional knockout parasites revealed that Atg8 and Atg3 are essential for Atg8 lipidation and autophagosome formation (<xref ref-type="bibr" rid="ref14">Besteiro et al., 2011</xref>).</p>
<p>Regarding the selectivity of the autophagic pathway, selective degradation of <italic>T. brucei</italic> glycosomes (peroxisome-like) was proposed during the differentiation from bloodstream trypomastigotes into procyclic forms. This target organelle is crucial for parasite survival and is involved in bioenergetic metabolism and antioxidant defenses, corroborating the pivotal role of pexophagy in this trypanosomatid (<xref ref-type="bibr" rid="ref66">Herman et al., 2008</xref>; <xref ref-type="bibr" rid="ref20">Brennand et al., 2015</xref>).</p>
<p>In general, autophagic phenotypes are very conserved, at least in pathogenic protozoans. Ultrastructural evidence (autophagosome formation, myelin-like structures and ER surrounding organelles) and Atg expression are frequently assessed in parasites under autophagic stimuli (<xref rid="fig5" ref-type="fig">Figures 5A</xref>&#x2013;<xref rid="fig5" ref-type="fig">D</xref>, <xref rid="fig6" ref-type="fig">6</xref>).</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>Transmission electron microscopy analysis of autophagic phenotypes conserved in pathogenic trypanosomatids. <bold>(A,C)</bold> <italic>Leishmania braziliensis</italic>. <bold>(B,D)</bold> <italic>Trypanosoma cruzi</italic>. <bold>(A&#x2013;D)</bold> Both parasites treated with drugs showed similar autophagic features such as the presence of autophagosomes (stars) and the formation of endoplasmic reticulum (ER) surrounding organelles (arrows). M, mitochondrion; K, kinetoplast; and N, nucleus. Bars&#x2009;=&#x2009;0.5&#x2009;&#x03BC;m.</p>
</caption>
<graphic xlink:href="fmicb-13-856686-g005.tif"/>
</fig>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption>
<p>Transmission electron microscopy analysis of autophagic phenotypes conserved in protozoan parasites. Trypanosomatids, apicomplexans, trichomonadids, and diplomonadids share similar ultrastructural features of autophagy such as endoplasmic reticulum (ER) surrounding organelles, the formation of autophagosomes and myelin-like structures (arrows). Bars&#x2009;=&#x2009;0.5&#x2009;&#x03BC;m.</p>
</caption>
<graphic xlink:href="fmicb-13-856686-g006.tif"/>
</fig>
</sec>
<sec id="sec12">
<title>Autophagic Phenotypes in Drug-Treated Parasites</title>
<p>Following the recent guidelines for monitoring autophagy, autophagic phenotypes in protozoa after treatment with drugs were assessed by different techniques, including Western blotting and electron and fluorescence microscopy (<xref ref-type="bibr" rid="ref78">Klionsky et al., 2021</xref>). Innumerous compounds from distinct classes induced different autophagic phenotypes (to different degrees) in protozoan parasites.</p>
<p>One of the most frequent morphological features of autophagy identified in these parasites is the presence of concentric membrane structures or myelin-like structures. Ultrastructural studies noted this structure in protozoa treated with all classes of compounds (<xref ref-type="bibr" rid="ref147">Vannier-Santos et al., 1995</xref>; <xref ref-type="bibr" rid="ref11">Benchimol, 1999</xref>; <xref ref-type="bibr" rid="ref19">Braga et al., 2005</xref>; <xref ref-type="bibr" rid="ref64">Granthon et al., 2006</xref>; <xref ref-type="bibr" rid="ref142">Uzc&#x00E1;tegui et al., 2007</xref>; <xref ref-type="bibr" rid="ref104">Menna-Barreto et al., 2009a</xref>,<xref ref-type="bibr" rid="ref106">b</xref>; <xref ref-type="bibr" rid="ref26">Carvalho et al., 2010</xref>; <xref ref-type="bibr" rid="ref17">Bomba&#x00E7;a et al., 2018</xref>, <xref ref-type="bibr" rid="ref16">2021</xref>; <xref ref-type="bibr" rid="ref100">Mart&#x00ED;nez-Garc&#x00ED;a et al., 2018</xref>; <xref ref-type="bibr" rid="ref5">Araujo-Silva et al., 2021</xref>).</p>
<p>The increased number of autophagosomes, a determinant of macroautophagy occurrence, is another very recurrent phenotype detected in treated protozoa (<xref ref-type="bibr" rid="ref19">Braga et al., 2005</xref>; <xref ref-type="bibr" rid="ref64">Granthon et al., 2006</xref>; <xref ref-type="bibr" rid="ref142">Uzc&#x00E1;tegui et al., 2007</xref>; <xref ref-type="bibr" rid="ref46">Dos Santos et al., 2010</xref>; <xref ref-type="bibr" rid="ref127">Schurigt et al., 2010</xref>; <xref ref-type="bibr" rid="ref14">Besteiro et al., 2011</xref>; <xref ref-type="bibr" rid="ref130">Sengupta et al., 2011</xref>; <xref ref-type="bibr" rid="ref55">Fernandes et al., 2012</xref>; <xref ref-type="bibr" rid="ref61">Ghosh et al., 2012</xref>; <xref ref-type="bibr" rid="ref150">Veiga-Santos et al., 2013</xref>; <xref ref-type="bibr" rid="ref138">Souto et al., 2016</xref>; <xref ref-type="bibr" rid="ref111">Nguyen et al., 2017b</xref>; <xref ref-type="bibr" rid="ref125">Scariot et al., 2017</xref>; <xref ref-type="bibr" rid="ref93">Lim et al., 2018</xref>; <xref ref-type="bibr" rid="ref100">Mart&#x00ED;nez-Garc&#x00ED;a et al., 2018</xref>; <xref ref-type="bibr" rid="ref67">Hernand&#x00E9;z-Garc&#x00ED;a et al., 2019</xref>; <xref ref-type="bibr" rid="ref70">Huang et al., 2019</xref>; <xref ref-type="bibr" rid="ref41">de Paula et al., 2020</xref>; <xref ref-type="bibr" rid="ref136">Silva et al., 2020</xref>; <xref ref-type="bibr" rid="ref112">Nishi et al., 2021</xref>; <xref ref-type="bibr" rid="ref165">Zhang et al., 2021</xref>).</p>
<p>As previously mentioned, Atg8 is considered the gold standard method for autophagic evaluation. Treatment of <italic>L. donovani</italic> with cryptolepine induced an increase in the number of Atg8 puncta (<xref ref-type="bibr" rid="ref130">Sengupta et al., 2011</xref>). Similar findings were observed in <italic>T. brucei</italic> treated with L-leucine methyl ester and bacteriocin AS-48 (<xref ref-type="bibr" rid="ref80">Koh et al., 2015</xref>; <xref ref-type="bibr" rid="ref100">Mart&#x00ED;nez-Garc&#x00ED;a et al., 2018</xref>). In <italic>T. gondii</italic>, starvation or treatment with the drug monensin or some antimalarial compounds induces a time-dependent accumulation of Atg8 puncta (<xref ref-type="bibr" rid="ref14">Besteiro et al., 2011</xref>; <xref ref-type="bibr" rid="ref83">Lavine and Arrizabalaga, 2012</xref>; <xref ref-type="bibr" rid="ref149">Varberg et al., 2018</xref>). Similar results were obtained when parasites were treated with the ER stress-inducing agents dithiothreitol, brefeldin A, or tunicamycin (<xref ref-type="bibr" rid="ref110">Nguyen et al., 2017a</xref>). Alternatively, the autofluorescent compound monodansyl cadaverine (MDC) is typically employed to assess autophagy, despite the nonspecificity of this marker. Several groups observed an increase in MDC labeling after the treatment of parasites with different compounds (<xref ref-type="bibr" rid="ref130">Sengupta et al., 2011</xref>; <xref ref-type="bibr" rid="ref55">Fernandes et al., 2012</xref>; <xref ref-type="bibr" rid="ref84">Lazarin-Bid&#x00F3;ia et al., 2013</xref>; <xref ref-type="bibr" rid="ref150">Veiga-Santos et al., 2013</xref>; <xref ref-type="bibr" rid="ref44">Desoti et al., 2014</xref>; <xref ref-type="bibr" rid="ref125">Scariot et al., 2017</xref>, <xref ref-type="bibr" rid="ref500">2019</xref>; <xref ref-type="bibr" rid="ref41">de Paula et al., 2020</xref>; <xref ref-type="bibr" rid="ref18">Bortoleti et al., 2021</xref>; <xref ref-type="bibr" rid="ref112">Nishi et al., 2021</xref>; <xref ref-type="bibr" rid="ref165">Zhang et al., 2021</xref>).</p>
<p>ER profiles surrounding cytoplasmic structures and organelles are also commonly detected in treated protozoa. <xref ref-type="bibr" rid="ref55">Fernandes et al. (2012)</xref> demonstrated that treatment with triazolic naphthoquinone led to the appearance of ER in close contact with reservosomes of <italic>T. cruzi</italic> epimastigotes. Especially in this case, the authors described the Golgi as an alternative source of the phagophoric membrane (<xref ref-type="bibr" rid="ref55">Fernandes et al., 2012</xref>). In <italic>L. amazonensis</italic>, elatol and amiodarona induced a similar phenotype and pronounced swelling of the mitochondrion and destabilization of the plasma membrane (<xref ref-type="bibr" rid="ref46">Dos Santos et al., 2010</xref>; <xref ref-type="bibr" rid="ref98">Macedo-Silva et al., 2011</xref>). In <italic>T. gondii</italic>, treatment with thiolactomycin analogs induced dramatic morphological changes in parasite shape and intracellular organization, including abnormal amounts of concentric membranes expanded throughout the parasite cytoplasm, possibly representing ER profiles (<xref ref-type="bibr" rid="ref101">Martins-Duarte et al., 2009</xref>).</p>
<p>To evaluate the specific role of autophagy in a drug mechanism of action, one of the most common experimental protocols is the treatment of parasites with autophagic inhibitors, such as wortmannin and 3-MA (<xref ref-type="bibr" rid="ref115">Pasquier, 2016</xref>; <xref ref-type="bibr" rid="ref78">Klionsky et al., 2021</xref>). In <italic>T. cruzi</italic>, the use of these inhibitors completely abolished the trypanocidal effect of naphthoimidazoles, reinforcing autophagy as part of the mechanism of cell death induced by these compounds (<xref ref-type="bibr" rid="ref104">Menna-Barreto et al., 2009a</xref>). Similar results were obtained with <italic>T. gondii</italic>, where preincubation with 3-MA efficiently abrogated the effects of monensin on mitochondrial fragmentation (<xref ref-type="bibr" rid="ref83">Lavine and Arrizabalaga, 2012</xref>). Interestingly, 3-MA was not able to prevent antimalarial compounds from the medicines for malaria venture malaria box MMV2- or MMV3-induced mitochondrial disruption, indicating that autophagy may occur downstream of mitochondrial fragmentation <italic>via</italic> PI3K-independent mechanisms (<xref ref-type="bibr" rid="ref149">Varberg et al., 2018</xref>).</p>
</sec>
<sec id="sec13">
<title>Concluding Remarks</title>
<p>Protozoan diseases still represent a significant challenge, demanding specific public health strategies, especially in low-income countries. Many of them are considered neglected diseases that impair physical and cognitive development, limiting individual productivity and resulting in economic issues (<xref ref-type="bibr" rid="ref160">World Health Organization, 2015</xref>; <xref ref-type="bibr" rid="ref300">Centers for Disease Control and Prevention, 2021d</xref>). Different parasite forms from a great variety of subpopulations also contribute to the increase in the drug resistance of pathogens, reinforcing the necessity of a continuous search for alternative compounds with anti-protozoan activity. During preclinical tests, cellular, molecular, and biochemical information about the targets of the novel compounds is critical for the characterization of drug safety and specificity.</p>
<p>Indeed, a detailed description of the mechanisms of action is still lacking, even for clinical drugs. As an example, the trypanocidal actions of benznidazole and nifurtimox, which are employed for Chagas disease treatment, are still not completely understood more than 50&#x2009;years after their discovery (<xref ref-type="bibr" rid="ref105">Menna-Barreto and De Castro, 2016</xref>). Furthermore, many new compounds with potent anti-protozoan activity do not exhibit predicted biological effects (<xref ref-type="bibr" rid="ref34">Chatelain and Ioset, 2011</xref>; <xref ref-type="bibr" rid="ref60">Gaspar et al., 2015</xref>), emphasizing the importance of the identification of effective molecular targets. Despite multidisciplinary efforts involving high-throughput screenings to discover novel candidates for the treatment of protozoan diseases (<xref ref-type="bibr" rid="ref4">Annang et al., 2015</xref>; <xref ref-type="bibr" rid="ref117">Pe&#x00F1;a et al., 2015</xref>), few studies have elucidated their mechanisms of action. One of the main reasons is the lack of efficient and practical tools to assess molecular drug targets <italic>in vitro</italic> and <italic>in vivo</italic>.</p>
<p>Electron microscopy was extensively employed in the first identification of primary drug targets in treated parasites, such as organelles and cellular structures (<xref ref-type="bibr" rid="ref35">Corr&#x00EA;a et al., 2009</xref>; <xref ref-type="bibr" rid="ref105">Menna-Barreto and De Castro, 2016</xref>). Ultrastructural analysis may allow inferences about the action of the compounds. Many studies also suggest the triggering of cell death processes as part of the drug mechanism (<xref ref-type="bibr" rid="ref99">Maia et al., 2007</xref>; <xref ref-type="bibr" rid="ref35">Corr&#x00EA;a et al., 2009</xref>; <xref ref-type="bibr" rid="ref104">Menna-Barreto et al., 2009a</xref>,<xref ref-type="bibr" rid="ref106">b</xref>; <xref ref-type="bibr" rid="ref103">Menna-Barreto, 2019</xref>). Despite all ultrastructural evidence, the occurrence of programmed cell death in protozoan parasites is very controversial due to the absence of precise information about biochemical and molecular events, especially those involved in regulatory processes (<xref ref-type="bibr" rid="ref103">Menna-Barreto, 2019</xref>). Until the convincing identification of the executioners, these phenotypes should be classified as unregulated processes or incidental necrosis (<xref ref-type="bibr" rid="ref119">Proto et al., 2013</xref>; <xref ref-type="bibr" rid="ref103">Menna-Barreto, 2019</xref>).</p>
<p>The treatment of different protozoa with distinct classes of drugs led to a convergent autophagic phenotype. Ultrastructural lesions in organelles, such as mitochondria, reservosomes, or hydrogenosomes, are usually closely associated with the appearance of endoplasmic reticulum profiles and an increase in the number of autophagosomes (<xref ref-type="bibr" rid="ref104">Menna-Barreto et al., 2009a</xref>,<xref ref-type="bibr" rid="ref106">b</xref>; <xref ref-type="bibr" rid="ref67">Hernand&#x00E9;z-Garc&#x00ED;a et al., 2019</xref>). Together with the formation of myelin-like structures, these are the most recurrent autophagy-related phenotypes described (<xref rid="fig7" ref-type="fig">Figure 7</xref>). Based on morphological findings, the autophagic role in cell death has been postulated, but a description of the regulatory events involved is lacking (<xref ref-type="bibr" rid="ref12">Bera et al., 2003</xref>; <xref ref-type="bibr" rid="ref9">Baehrecke, 2005</xref>; <xref ref-type="bibr" rid="ref104">Menna-Barreto et al., 2009a</xref>). It is well known that autophagy plays a pivotal role in homeostasis maintenance in eukaryotes, including protozoan parasites. Drugs impair different molecular pathways, causing the loss of the balance in the turnover of crucial cellular structures. Such an imbalance promotes an exacerbation of nonselective autophagy, culminating in nonspecific damage (<xref ref-type="bibr" rid="ref9">Baehrecke, 2005</xref>). This is a reasonable explanation for the appearance of the autophagic phenotype in treated parasites regardless of the drug and/or mechanism of action involved (<xref ref-type="bibr" rid="ref106">Menna-Barreto et al., 2009b</xref>; <xref ref-type="bibr" rid="ref103">Menna-Barreto, 2019</xref>). In summary, autophagy represents survival machinery responsible for the removal of cellular structures damaged by compounds.</p>
<fig position="float" id="fig7">
<label>Figure 7</label>
<caption>
<p>Mechanistic proposal of autophagy in the mode of action of anti-protozoa drugs. Compounds with distinct mechanisms of action lead to the impairment of cellular structures such as organelles and macromolecules. Such damaged structures are randomly engulfed by a phagophore in a Atg-dependent process, forming an autophagosome. After the fusion with lysosome, the cargo is degraded inside the autophagolysosome. The non-selective continuous autophagic exacerbation promotes the breakage of the protozoa homeostasis, culminating in an accumulation of a high number of autophagic vacuoles (autophagosomes and/or autophagolysosomes) and consequent autophagic cell death. This process could be at least partially inhibited by the pre-incubation with classical PI-3 kinase inhibitors as wortmannin or 3-methyladenine.</p>
</caption>
<graphic xlink:href="fmicb-13-856686-g007.tif"/>
</fig>
</sec>
<sec id="sec14">
<title>Author Contributions</title>
<p>RM-B conceived the work and drafted the manuscript. YP-R and RM-B wrote trypanosomatids subjects. RM and IM wrote the apicomplexan part. VM wrote about anaerobic parasites. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="sec41" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by CNPq, CAPES, FAPERJ, and FIOCRUZ.</p>
</sec>
<sec id="conf1" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec16" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack>
<p>We are very thankful to Antonio Pereira-Neves from CPqAM/Fiocruz, Brazil, for kindly providing all ultrastructural images of <italic>Trichomonas</italic> and for his helpful discussions about autophagic process in these parasites as well. We also thank Helene Santos Barbosa from IOC/Fiocruz, Brazil, for kindly providing the ER profiles and myelin-like structures ultrastructural images of <italic>Toxoplasma</italic>.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="ref1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abdrakhmanov</surname> <given-names>A.</given-names></name> <name><surname>Gogvadze</surname> <given-names>V.</given-names></name> <name><surname>Zhivotovsky</surname> <given-names>B.</given-names></name></person-group> (<year>2020</year>). <article-title>To eat or to die: deciphering selective forms of autophagy</article-title>. <source>Trends Biochem. Sci.</source> <volume>45</volume>, <fpage>347</fpage>&#x2013;<lpage>364</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tibs.2019.11.006</pub-id>, PMID: <pub-id pub-id-type="pmid">32044127</pub-id></citation></ref>
<ref id="ref2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Allain</surname> <given-names>T.</given-names></name> <name><surname>Buret</surname> <given-names>A. G.</given-names></name></person-group> (<year>2020</year>). <article-title>Pathogenesis and post-infectious complications in giardiasis</article-title>. <source>Adv. Parasitol.</source> <volume>107</volume>, <fpage>173</fpage>&#x2013;<lpage>199</lpage>. doi: <pub-id pub-id-type="doi">10.1016/bs.apar.2019.12.001</pub-id></citation></ref>
<ref id="ref3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alvarez</surname> <given-names>V. E.</given-names></name> <name><surname>Kosec</surname> <given-names>G.</given-names></name> <name><surname>Sant&#x2019;Anna</surname> <given-names>C.</given-names></name> <name><surname>Turk</surname> <given-names>V.</given-names></name> <name><surname>Cazzulo</surname> <given-names>J. J.</given-names></name> <name><surname>Turk</surname> <given-names>B.</given-names></name></person-group> (<year>2008</year>). <article-title>Blocking autophagy to prevent parasite differentiation: a possible new strategy for fighting parasitic infections?</article-title> <source>Autophagy</source> <volume>4</volume>, <fpage>361</fpage>&#x2013;<lpage>363</lpage>. doi: <pub-id pub-id-type="doi">10.4161/auto.5592</pub-id></citation></ref>
<ref id="ref4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Annang</surname> <given-names>F.</given-names></name> <name><surname>P&#x00E9;rez-Moreno</surname> <given-names>G.</given-names></name> <name><surname>Garc&#x00ED;a-Hern&#x00E1;ndez</surname> <given-names>R.</given-names></name> <name><surname>Cordon-Obras</surname> <given-names>C.</given-names></name> <name><surname>Mart&#x00ED;n</surname> <given-names>J.</given-names></name> <name><surname>Tormo</surname> <given-names>J. R.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and chagas disease</article-title>. <source>J. Biomol. Screen.</source> <volume>20</volume>, <fpage>82</fpage>&#x2013;<lpage>91</lpage>. doi: <pub-id pub-id-type="doi">10.1177/1087057114555846</pub-id>, PMID: <pub-id pub-id-type="pmid">25332350</pub-id></citation></ref>
<ref id="ref5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Araujo-Silva</surname> <given-names>C. A.</given-names></name> <name><surname>De Souza</surname> <given-names>W.</given-names></name> <name><surname>Martins-Duarte</surname> <given-names>E. S.</given-names></name> <name><surname>Vommaro</surname> <given-names>R. C.</given-names></name></person-group> (<year>2021</year>). <article-title>HDAC inhibitors Tubastatin A and SAHA affect parasite cell division and are potential anti-<italic>Toxoplasma gondii</italic> chemotherapeutics</article-title>. <source>Int. J. Parasitol. Drugs Drug Resist.</source> <volume>15</volume>, <fpage>25</fpage>&#x2013;<lpage>35</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijpddr.2020.12.003</pub-id>, PMID: <pub-id pub-id-type="pmid">33360687</pub-id></citation></ref>
<ref id="ref6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arg&#x00FC;ello-Garc&#x00ED;a</surname> <given-names>R.</given-names></name> <name><surname>Leitsch</surname> <given-names>D.</given-names></name> <name><surname>Skinner-Adams</surname> <given-names>T.</given-names></name> <name><surname>Ortega-Pierres</surname> <given-names>M. G.</given-names></name></person-group> (<year>2020</year>). <article-title>Drug resistance in giardia: mechanisms and alternative treatments for giardiasis</article-title>. <source>Adv. Parasitol.</source> <volume>107</volume>, <fpage>201</fpage>&#x2013;<lpage>282</lpage>. doi: <pub-id pub-id-type="doi">10.1016/bs.apar.2019.11.003</pub-id></citation></ref>
<ref id="ref7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aronson</surname> <given-names>N.</given-names></name> <name><surname>Herwaldt</surname> <given-names>B. L.</given-names></name> <name><surname>Libman</surname> <given-names>M.</given-names></name> <name><surname>Pearson</surname> <given-names>R.</given-names></name> <name><surname>Lopez-Velez</surname> <given-names>R.</given-names></name> <name><surname>Weina</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)</article-title>. <source>Clin. Infect. Dis.</source> <volume>63</volume>, <fpage>e202</fpage>&#x2013;<lpage>e264</lpage>. doi: <pub-id pub-id-type="doi">10.1093/cid/ciw670</pub-id>, PMID: <pub-id pub-id-type="pmid">27941151</pub-id></citation></ref>
<ref id="ref8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Babokhov</surname> <given-names>P.</given-names></name> <name><surname>Sanyaolu</surname> <given-names>A. O.</given-names></name> <name><surname>Oyibo</surname> <given-names>W. A.</given-names></name> <name><surname>Fagbenro-Beyioku</surname> <given-names>A. F.</given-names></name> <name><surname>Iriemenam</surname> <given-names>N. C.</given-names></name></person-group> (<year>2013</year>). <article-title>A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis</article-title>. <source>Pathog. Glob. Health</source> <volume>107</volume>, <fpage>242</fpage>&#x2013;<lpage>252</lpage>. doi: <pub-id pub-id-type="doi">10.1179/2047773213Y.0000000105</pub-id>, PMID: <pub-id pub-id-type="pmid">23916333</pub-id></citation></ref>
<ref id="ref9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baehrecke</surname> <given-names>E. H.</given-names></name></person-group> (<year>2005</year>). <article-title>Autophagy: dual roles in life and death?</article-title> <source>Nat. Rev. Mol. Cell Biol.</source> <volume>6</volume>, <fpage>505</fpage>&#x2013;<lpage>510</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrm1666</pub-id>, PMID: <pub-id pub-id-type="pmid">15928714</pub-id></citation></ref>
<ref id="ref10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barquilla</surname> <given-names>A.</given-names></name> <name><surname>Crespo</surname> <given-names>J. L.</given-names></name> <name><surname>Navarro</surname> <given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Rapamycin inhibits trypanosome cell growth by preventing TOR complex 2 formation</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>105</volume>, <fpage>14579</fpage>&#x2013;<lpage>14584</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0802668105</pub-id>, PMID: <pub-id pub-id-type="pmid">18796613</pub-id></citation></ref>
<ref id="ref11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benchimol</surname> <given-names>M.</given-names></name></person-group> (<year>1999</year>). <article-title>Hydrogenosome autophagy: an ultrastructural and cytochemical study</article-title>. <source>Biol. Cell.</source> <volume>91</volume>, <fpage>165</fpage>&#x2013;<lpage>174</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0248-4900(99)80039-2</pub-id></citation></ref>
<ref id="ref12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bera</surname> <given-names>A.</given-names></name> <name><surname>Singh</surname> <given-names>S.</given-names></name> <name><surname>Nagaraj</surname> <given-names>R.</given-names></name> <name><surname>Vaidya</surname> <given-names>T.</given-names></name></person-group> (<year>2003</year>). <article-title>Induction of autophagic cell death in <italic>Leishmania donovani</italic> by antimicrobial peptides</article-title>. <source>Mol. Biochem. Parasitol.</source> <volume>127</volume>, <fpage>23</fpage>&#x2013;<lpage>35</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0166-6851(02)00300-6</pub-id>, PMID: <pub-id pub-id-type="pmid">12615333</pub-id></citation></ref>
<ref id="ref13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Besteiro</surname> <given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Autophagy in apicomplexan parasites</article-title>. <source>Curr. Opin. Microbiol.</source> <volume>40</volume>, <fpage>14</fpage>&#x2013;<lpage>20</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mib.2017.10.008</pub-id>, PMID: <pub-id pub-id-type="pmid">29096193</pub-id></citation></ref>
<ref id="ref14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Besteiro</surname> <given-names>S.</given-names></name> <name><surname>Brooks</surname> <given-names>C. F.</given-names></name> <name><surname>Striepen</surname> <given-names>B.</given-names></name> <name><surname>Dubremetz</surname> <given-names>J. F.</given-names></name></person-group> (<year>2011</year>). <article-title>Autophagy protein Atg3 is essential for maintaining mitochondrial integrity and for normal intracellular development of <italic>Toxoplasma gondii</italic> tachyzoites</article-title>. <source>PLoS Pathog.</source> <volume>7</volume>:<fpage>e1002416</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1002416</pub-id>, PMID: <pub-id pub-id-type="pmid">22144900</pub-id></citation></ref>
<ref id="ref15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Besteiro</surname> <given-names>S.</given-names></name> <name><surname>Williams</surname> <given-names>R. A. M.</given-names></name> <name><surname>Morrison</surname> <given-names>L. S.</given-names></name> <name><surname>Coombs</surname> <given-names>G. H.</given-names></name> <name><surname>Mottram</surname> <given-names>J. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Endosome sorting and autophagy are essential for differentiation and virulence of <italic>Leishmania</italic> major</article-title>. <source>J. Biol. Chem.</source> <volume>281</volume>, <fpage>11384</fpage>&#x2013;<lpage>11396</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M512307200</pub-id>, PMID: <pub-id pub-id-type="pmid">16497676</pub-id></citation></ref>
<ref id="ref16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bomba&#x00E7;a</surname> <given-names>A. C. S.</given-names></name> <name><surname>Silva</surname> <given-names>L. A.</given-names></name> <name><surname>Chaves</surname> <given-names>O. A.</given-names></name> <name><surname>da Silva</surname> <given-names>L. S.</given-names></name> <name><surname>Barbosa</surname> <given-names>J. M. C.</given-names></name> <name><surname>da Silva</surname> <given-names>A. M.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Novel N,N-di-alkylnaphthoimidazolium derivative of &#x03B2;-lapachone impaired <italic>Trypanosoma cruzi</italic> mitochondrial electron transport system</article-title>. <source>Biomed. Pharmacother.</source> <volume>135</volume>:<fpage>111186</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biopha.2020.111186</pub-id>, PMID: <pub-id pub-id-type="pmid">33395606</pub-id></citation></ref>
<ref id="ref17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bomba&#x00E7;a</surname> <given-names>A. C. S.</given-names></name> <name><surname>Von Dossow</surname> <given-names>D.</given-names></name> <name><surname>Barbosa</surname> <given-names>J. M. C.</given-names></name> <name><surname>Paz</surname> <given-names>C.</given-names></name> <name><surname>Burgos</surname> <given-names>V.</given-names></name> <name><surname>Menna-Barreto</surname> <given-names>R. F. S.</given-names></name></person-group> (<year>2018</year>). <article-title>Trypanocidal activity of natural sesquiterpenoids involves mitochondrial dysfunction, ROS production and autophagic phenotype in trypanosomacruzi</article-title>. <source>Molecules</source> <volume>23</volume>:<fpage>2800</fpage>. doi: <pub-id pub-id-type="doi">10.3390/molecules23112800</pub-id>, PMID: <pub-id pub-id-type="pmid">30373326</pub-id></citation></ref>
<ref id="ref18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bortoleti</surname> <given-names>B.</given-names></name> <name><surname>Gon&#x00E7;alves</surname> <given-names>M. D.</given-names></name> <name><surname>Tomiotto-Pellissier</surname> <given-names>F.</given-names></name> <name><surname>Contato</surname> <given-names>V. M.</given-names></name> <name><surname>Silva</surname> <given-names>T. F.</given-names></name> <name><surname>de Matos</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Solidagenone acts on promastigotes of <italic>L. amazonensis</italic> by inducing apoptosis-like processes on intracellular amastigotes by IL-12p70/ROS/NO pathway activation</article-title>. <source>Phytomedicine</source> <volume>85</volume>:<fpage>153536</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.phymed.2021.153536</pub-id>, PMID: <pub-id pub-id-type="pmid">33765552</pub-id></citation></ref>
<ref id="ref19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Braga</surname> <given-names>M. V.</given-names></name> <name><surname>Magaraci</surname> <given-names>F.</given-names></name> <name><surname>Lorente</surname> <given-names>S. O.</given-names></name> <name><surname>Gilbert</surname> <given-names>I.</given-names></name> <name><surname>de Souza</surname> <given-names>W.</given-names></name></person-group> (<year>2005</year>). <article-title>Effects of inhibitors of &#x0394;24(25)-sterol methyl transferase on the ultrastructure of epimastigotes of <italic>Trypanosoma cruzi</italic></article-title>. <source>Microsc. Microanal.</source> <volume>11</volume>, <fpage>506</fpage>&#x2013;<lpage>515</lpage>. doi: <pub-id pub-id-type="doi">10.1017/S143192760505035X</pub-id>, PMID: <pub-id pub-id-type="pmid">17481329</pub-id></citation></ref>
<ref id="ref20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brennand</surname> <given-names>A.</given-names></name> <name><surname>Rico</surname> <given-names>E.</given-names></name> <name><surname>Rigden</surname> <given-names>D. J.</given-names></name> <name><surname>Van Der Smissen</surname> <given-names>P.</given-names></name> <name><surname>Courtoy</surname> <given-names>P. J.</given-names></name> <name><surname>Michels</surname> <given-names>P. A.</given-names></name></person-group> (<year>2015</year>). <article-title>ATG24 represses autophagy and differentiation and is essential for homeostasy of the flagellar pocket in <italic>Trypanosoma brucei</italic></article-title>. <source>PLoS One</source> <volume>10</volume>:<fpage>e0130365</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0130365</pub-id>, PMID: <pub-id pub-id-type="pmid">26090847</pub-id></citation></ref>
<ref id="ref21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Briolant</surname> <given-names>S.</given-names></name> <name><surname>Almeras</surname> <given-names>L.</given-names></name> <name><surname>Belghazi</surname> <given-names>M.</given-names></name> <name><surname>Boucomont-Chapeaublanc</surname> <given-names>E.</given-names></name> <name><surname>Wurtz</surname> <given-names>N.</given-names></name> <name><surname>Fontaine</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Plasmodium falciparum proteome changes in response to doxycycline treatment</article-title>. <source>Malar. J.</source> <volume>9</volume>:<fpage>141</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1475-2875-9-141</pub-id>, PMID: <pub-id pub-id-type="pmid">20500856</pub-id></citation></ref>
<ref id="ref22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brisson-No&#x00EB;l</surname> <given-names>A.</given-names></name> <name><surname>Trieu-Cuot</surname> <given-names>P.</given-names></name> <name><surname>Courvalin</surname> <given-names>P.</given-names></name></person-group> (<year>1988</year>). <article-title>Mechanism of action of spiramycin and other macrolides</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>22</volume>(<issue>Suppl B</issue>), <fpage>13</fpage>&#x2013;<lpage>23</lpage>.</citation></ref>
<ref id="ref23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brook</surname> <given-names>I.</given-names></name></person-group> (<year>1998</year>). <article-title>Pharmacodynamics and pharmacokinetics of Spiramycin and their clinical significance</article-title>. <source>Clin. Pharmacokinet.</source> <volume>34</volume>, <fpage>303</fpage>&#x2013;<lpage>310</lpage>. doi: <pub-id pub-id-type="doi">10.2165/00003088-199834040-00003</pub-id>, PMID: <pub-id pub-id-type="pmid">9571302</pub-id></citation></ref>
<ref id="ref24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Busatti</surname> <given-names>H. G.</given-names></name> <name><surname>Alves</surname> <given-names>R. J.</given-names></name> <name><surname>Santana-Anjos</surname> <given-names>K. G.</given-names></name> <name><surname>Gil</surname> <given-names>F. F.</given-names></name> <name><surname>Cury</surname> <given-names>M. C.</given-names></name> <name><surname>Vannier-Santos</surname> <given-names>M. A.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Effects of metronidazole analogues on Giardia lamblia: experimental infection and cell organization</article-title>. <source>Diagn. Microbiol. Infect. Dis.</source> <volume>75</volume>, <fpage>160</fpage>&#x2013;<lpage>164</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2012.11.001</pub-id>, PMID: <pub-id pub-id-type="pmid">23331963</pub-id></citation></ref>
<ref id="ref25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Capewell</surname> <given-names>P.</given-names></name> <name><surname>Krumrie</surname> <given-names>S.</given-names></name> <name><surname>Katzer</surname> <given-names>F.</given-names></name> <name><surname>Alexander</surname> <given-names>C. L.</given-names></name> <name><surname>Weir</surname> <given-names>W.</given-names></name></person-group> (<year>2021</year>). <article-title>Molecular epidemiology of giardia infections in the genomic era</article-title>. <source>Trends Parasitol.</source> <volume>37</volume>, <fpage>142</fpage>&#x2013;<lpage>153</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.pt.2020.09.013</pub-id>, PMID: <pub-id pub-id-type="pmid">33067130</pub-id></citation></ref>
<ref id="ref26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname> <given-names>C. S.</given-names></name> <name><surname>Melo</surname> <given-names>E. J.</given-names></name> <name><surname>Ten&#x00F3;rio</surname> <given-names>R. P.</given-names></name> <name><surname>G&#x00F3;es</surname> <given-names>A. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Anti-parasitic action and elimination of intracellular <italic>Toxoplasma gondii</italic> in the presence of novel thiosemicarbazone and its 4-thiazolidinone derivatives</article-title>. <source>Braz. J. Med. Biol. Res.</source> <volume>43</volume>, <fpage>139</fpage>&#x2013;<lpage>149</lpage>. doi: <pub-id pub-id-type="doi">10.1590/s0100-879x2009005000038</pub-id>, PMID: <pub-id pub-id-type="pmid">19893994</pub-id></citation></ref>
<ref id="ref28"><citation citation-type="other"><person-group person-group-type="author"><collab id="coll2">Centers for Disease Control and Prevention</collab></person-group> (<year>2019</year>). African Trypanosomiasis. Available at: <ext-link xlink:href="https://www.cdc.gov/parasites/sleepingsickness/index.html" ext-link-type="uri">https://www.cdc.gov/parasites/sleepingsickness/index.html</ext-link> (Accessed March 18, 2019).</citation></ref>
<ref id="ref27"><citation citation-type="other"><person-group person-group-type="author"><collab id="coll1">Centers for Disease Control and Prevention</collab></person-group> (<year>2021a</year>). Leishmaniasis. Available at: <ext-link xlink:href="https://www.cdc.gov/parasites/leishmaniasis/index.html" ext-link-type="uri">https://www.cdc.gov/parasites/leishmaniasis/index.html</ext-link> (Accessed March 16, 2021).</citation></ref>
<ref id="ref29"><citation citation-type="other"><person-group person-group-type="author"><collab id="coll3">Centers for Disease Control and Prevention</collab></person-group> (<year>2021b</year>). Toxoplasmosis. Available at: <ext-link xlink:href="https://www.cdc.gov/parasites/toxoplasmosis/index.html" ext-link-type="uri">https://www.cdc.gov/parasites/toxoplasmosis/index.html</ext-link> (Accessed August 19, 2021).</citation></ref>
<ref id="ref30"><citation citation-type="other"><person-group person-group-type="author"><collab id="coll4">Centers for Disease Control and Prevention</collab></person-group> (<year>2021c</year>). Malaria. Available at: <ext-link xlink:href="https://www.cdc.gov/parasites/malaria/index.html" ext-link-type="uri">https://www.cdc.gov/parasites/malaria/index.html</ext-link> (Accessed September 18, 2021).</citation></ref>
<ref id="ref300"><citation citation-type="other"><person-group person-group-type="author"><collab id="coll4999">Centers for Disease Control and Prevention</collab></person-group> (<year>2021d</year>). Diseases. Available at: <ext-link xlink:href="https://www.cdc.gov/globalhealth/ntd/diseases/index.html" ext-link-type="uri">https://www.cdc.gov/globalhealth/ntd/diseases/index.html</ext-link> (Accessed September 20, 2021).</citation></ref>
<ref id="ref31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cernikova</surname> <given-names>L.</given-names></name> <name><surname>Faso</surname> <given-names>C.</given-names></name> <name><surname>Hehl</surname> <given-names>A. B.</given-names></name></person-group> (<year>2020</year>). <article-title>Phosphoinositide-binding proteins mark, shape and functionally modulate highly-diverged endocytic compartments in the parasitic protist <italic>Giardia lamblia</italic></article-title>. <source>PLoS Pathog.</source> <volume>16</volume>:<fpage>e1008317</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1008317</pub-id>, PMID: <pub-id pub-id-type="pmid">32092130</pub-id></citation></ref>
<ref id="ref32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Certad</surname> <given-names>G.</given-names></name> <name><surname>Viscogliosi</surname> <given-names>E.</given-names></name> <name><surname>Chab&#x00E9;</surname> <given-names>M.</given-names></name> <name><surname>Cacci&#x00F2;</surname> <given-names>S. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Pathogenic mechanisms of <italic>Cryptosporidium</italic> and <italic>Giardia</italic></article-title>. <source>Trends Parasitol.</source> <volume>33</volume>, <fpage>561</fpage>&#x2013;<lpage>576</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.pt.2017.02.006</pub-id>, PMID: <pub-id pub-id-type="pmid">28336217</pub-id></citation></ref>
<ref id="ref33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chac&#x00ED;n-Bonilla</surname> <given-names>L.</given-names></name></person-group> (<year>2013</year>). <article-title>An update on amebiasis</article-title>. <source>Rev. Med. Chil.</source> <volume>141</volume>, <fpage>609</fpage>&#x2013;<lpage>615</lpage>. doi: <pub-id pub-id-type="doi">10.4067/S0034-98872013000500009</pub-id>, PMID: <pub-id pub-id-type="pmid">24089276</pub-id></citation></ref>
<ref id="ref34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chatelain</surname> <given-names>E.</given-names></name> <name><surname>Ioset</surname> <given-names>J. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Drug discovery and development for neglected diseases: the DNDi model</article-title>. <source>Drug Des. Devel. Ther.</source> <volume>5</volume>, <fpage>175</fpage>&#x2013;<lpage>181</lpage>. doi: <pub-id pub-id-type="doi">10.2147/DDDT.S16381</pub-id>, PMID: <pub-id pub-id-type="pmid">21552487</pub-id></citation></ref>
<ref id="ref35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Corr&#x00EA;a</surname> <given-names>G.</given-names></name> <name><surname>Vilela</surname> <given-names>R.</given-names></name> <name><surname>Menna-Barreto</surname> <given-names>R. F.</given-names></name> <name><surname>Midlej</surname> <given-names>V.</given-names></name> <name><surname>Benchimol</surname> <given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Cell death induction in <italic>Giardia lamblia</italic>: effect of beta-lapachone and starvation</article-title>. <source>Parasitol. Int.</source> <volume>58</volume>, <fpage>424</fpage>&#x2013;<lpage>437</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.parint.2009.08.006</pub-id>, PMID: <pub-id pub-id-type="pmid">19703583</pub-id></citation></ref>
<ref id="ref36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cotter</surname> <given-names>C.</given-names></name> <name><surname>Sturrock</surname> <given-names>H. J.</given-names></name> <name><surname>Hsiang</surname> <given-names>M. S.</given-names></name> <name><surname>Liu</surname> <given-names>J.</given-names></name> <name><surname>Phillips</surname> <given-names>A. A.</given-names></name> <name><surname>Hwang</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>The changing epidemiology of malaria elimination: new strategies for new challenges</article-title>. <source>Lancet</source> <volume>382</volume>, <fpage>900</fpage>&#x2013;<lpage>911</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(13)60310-4</pub-id>, PMID: <pub-id pub-id-type="pmid">23594387</pub-id></citation></ref>
<ref id="ref37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cowman</surname> <given-names>A. F.</given-names></name> <name><surname>Healer</surname> <given-names>J.</given-names></name> <name><surname>Marapana</surname> <given-names>D.</given-names></name> <name><surname>Marsh</surname> <given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>Malaria: biology and disease</article-title>. <source>Cell</source> <volume>167</volume>, <fpage>610</fpage>&#x2013;<lpage>624</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2016.07.055</pub-id>, PMID: <pub-id pub-id-type="pmid">27768886</pub-id></citation></ref>
<ref id="ref38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cudmore</surname> <given-names>S. L.</given-names></name> <name><surname>Garber</surname> <given-names>G. E.</given-names></name></person-group> (<year>2010</year>). <article-title>Prevention or treatment: the benefits of <italic>Trichomonas vaginalis</italic> vaccine</article-title>. <source>J. Infect. Public Health</source> <volume>3</volume>, <fpage>47</fpage>&#x2013;<lpage>53</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jiph.2010.01.003</pub-id>, PMID: <pub-id pub-id-type="pmid">20701891</pub-id></citation></ref>
<ref id="ref39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dahl</surname> <given-names>E. L.</given-names></name> <name><surname>Shock</surname> <given-names>J. L.</given-names></name> <name><surname>Shenai</surname> <given-names>B. R.</given-names></name> <name><surname>Gut</surname> <given-names>J.</given-names></name> <name><surname>DeRisi</surname> <given-names>J. L.</given-names></name> <name><surname>Rosenthal</surname> <given-names>P. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Tetracyclines specifically target the apicoplast of the malaria parasite <italic>Plasmodium falciparum</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>50</volume>, <fpage>3124</fpage>&#x2013;<lpage>3131</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.00394-06</pub-id>, PMID: <pub-id pub-id-type="pmid">16940111</pub-id></citation></ref>
<ref id="ref40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Menezes</surname> <given-names>J. P. B.</given-names></name> <name><surname>Guedes</surname> <given-names>C. E. S.</given-names></name> <name><surname>Petersen</surname> <given-names>A. L. O. A.</given-names></name> <name><surname>Fraga</surname> <given-names>D. B. M.</given-names></name> <name><surname>Veras</surname> <given-names>P. S. T.</given-names></name></person-group> (<year>2015</year>). <article-title>Advances in development of new treatment for leishmaniasis</article-title>. <source>Biomed. Res. Int.</source> <volume>2015</volume>:<fpage>815023</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2015/815023</pub-id>, PMID: <pub-id pub-id-type="pmid">26078965</pub-id></citation></ref>
<ref id="ref41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Paula</surname> <given-names>J. C.</given-names></name> <name><surname>Bakoshic</surname> <given-names>A. B. K.</given-names></name> <name><surname>Lazarin-Bid&#x00F3;ia</surname> <given-names>D.</given-names></name> <name><surname>Ud Din</surname> <given-names>Z.</given-names></name> <name><surname>Rodrigues-Filho</surname> <given-names>E.</given-names></name> <name><surname>Ueda-Nakamura</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Antiproliferative activity of the dibenzylideneacetone derivate (E)-3-ethyl-4-(4-nitrophenyl)but-3-en-2-one in <italic>Trypanosoma cruzi</italic></article-title>. <source>Acta Trop.</source> <volume>211</volume>:<fpage>105653</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.actatropica.2020.105653</pub-id>, PMID: <pub-id pub-id-type="pmid">32777226</pub-id></citation></ref>
<ref id="ref42"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Delgado</surname> <given-names>M. J. P.</given-names></name> <name><surname>Gasc&#x00F3;n</surname> <given-names>J.</given-names></name></person-group> (<year>2020</year>). <source>Chagas Disease: A Negleted Tropical Disease.</source> <publisher-loc>Switzerland</publisher-loc>: <publisher-name>Springer</publisher-name>.</citation></ref>
<ref id="ref43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Denninger</surname> <given-names>V.</given-names></name> <name><surname>Koopmann</surname> <given-names>R.</given-names></name> <name><surname>Muhammad</surname> <given-names>K.</given-names></name> <name><surname>Barth</surname> <given-names>T.</given-names></name> <name><surname>Bassarak</surname> <given-names>B.</given-names></name> <name><surname>Sch&#x00F6;nfeld</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>Kinetoplastida: model organisms for simple autophagic pathways?</article-title> <source>Methods Enzymol.</source> <volume>451</volume>, <fpage>373</fpage>&#x2013;<lpage>408</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0076-6879(08)03225-4</pub-id></citation></ref>
<ref id="ref44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Desoti</surname> <given-names>V. C.</given-names></name> <name><surname>Lazarin-Bid&#x00F3;ia</surname> <given-names>D.</given-names></name> <name><surname>Sudatti</surname> <given-names>D. B.</given-names></name> <name><surname>Pereira</surname> <given-names>R. C.</given-names></name> <name><surname>Ueda-Nakamura</surname> <given-names>T.</given-names></name> <name><surname>Nakamura</surname> <given-names>C. V.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Additional evidence of the trypanocidal action of (&#x2212;)-elatol on amastigote forms through the involvement of reactive oxygen species</article-title>. <source>Mar. Drugs</source> <volume>12</volume>, <fpage>4973</fpage>&#x2013;<lpage>4983</lpage>. doi: <pub-id pub-id-type="doi">10.3390/md12094973</pub-id>, PMID: <pub-id pub-id-type="pmid">25257785</pub-id></citation></ref>
<ref id="ref45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dias</surname> <given-names>J. C. P.</given-names></name> <name><surname>Ramos</surname> <given-names>A. N.</given-names></name> <name><surname>Gontijo</surname> <given-names>E. D.</given-names></name> <name><surname>Luquetti</surname> <given-names>A.</given-names></name> <name><surname>Shikanai-Yasuda</surname> <given-names>M. A.</given-names></name> <name><surname>Coura</surname> <given-names>J. R.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>2 nd Brazilian Consensus on Chagas disease</article-title>. <source>Rev. Soc. Bras. Med. Trop.</source> <volume>49</volume>(<issue>Suppl 1</issue>), <fpage>3</fpage>&#x2013;<lpage>60</lpage>. doi: <pub-id pub-id-type="doi">10.1590/0037-8682-0505-2016</pub-id></citation></ref>
<ref id="ref46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dos Santos</surname> <given-names>A. O.</given-names></name> <name><surname>Veiga-Santos</surname> <given-names>P.</given-names></name> <name><surname>Ueda-Nakamura</surname> <given-names>T.</given-names></name> <name><surname>Filho</surname> <given-names>B. P.</given-names></name> <name><surname>Sudatti</surname> <given-names>D. B.</given-names></name> <name><surname>Bianco</surname> <given-names>E. M.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Effect of elatol, isolated from red seaweed <italic>Laurencia dendroidea</italic>, on <italic>Leishmania amazonensis</italic></article-title>. <source>Mar. Drugs</source> <volume>8</volume>, <fpage>2733</fpage>&#x2013;<lpage>2743</lpage>. doi: <pub-id pub-id-type="doi">10.3390/md8112733</pub-id>, PMID: <pub-id pub-id-type="pmid">21139841</pub-id></citation></ref>
<ref id="ref47"><citation citation-type="other"><person-group person-group-type="author"><collab id="coll5">Drugs for Negleted Diseases initiative</collab></person-group> (<year>2020</year>). Sleeping Sickness. Available at: <ext-link xlink:href="https://dndi.org/diseases/sleeping-sickness/" ext-link-type="uri">https://dndi.org/diseases/sleeping-sickness/</ext-link> (Accessed March 5, 2020).</citation></ref>
<ref id="ref48"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Dubey</surname> <given-names>J. P.</given-names></name></person-group> (<year>2010</year>). <source>Toxoplasmosis of Animals and Humans.</source> <publisher-loc>Boca Raton, Florida</publisher-loc>: <publisher-name>CRC Press</publisher-name>.</citation></ref>
<ref id="ref49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dunay</surname> <given-names>I. R.</given-names></name> <name><surname>Gajurel</surname> <given-names>K.</given-names></name> <name><surname>Dhakal</surname> <given-names>R.</given-names></name> <name><surname>Liesenfeld</surname> <given-names>O.</given-names></name> <name><surname>Montoya</surname> <given-names>J. G.</given-names></name></person-group> (<year>2018</year>). <article-title>Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>31</volume>, <fpage>e00057</fpage>&#x2013;<lpage>e00117</lpage>. doi: <pub-id pub-id-type="doi">10.1128/CMR.00057-17</pub-id></citation></ref>
<ref id="ref50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duszenko</surname> <given-names>M.</given-names></name> <name><surname>Ginger</surname> <given-names>M. L.</given-names></name> <name><surname>Brennand</surname> <given-names>A.</given-names></name> <name><surname>Gualdr&#x00F3;n-L&#x00F3;pez</surname> <given-names>M.</given-names></name> <name><surname>Colombo</surname> <given-names>M. I.</given-names></name> <name><surname>Coombs</surname> <given-names>G. H.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Autophagy in protists</article-title>. <source>Autophagy</source> <volume>7</volume>, <fpage>127</fpage>&#x2013;<lpage>158</lpage>. doi: <pub-id pub-id-type="doi">10.4161/auto.7.2.13310</pub-id></citation></ref>
<ref id="ref51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Edlind</surname> <given-names>T. D.</given-names></name></person-group> (<year>1989</year>). <article-title>Susceptibility of <italic>Giardia lamblia</italic> to aminoglycoside protein synthesis inhibitors: correlation with rRNA structure</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>33</volume>, <fpage>484</fpage>&#x2013;<lpage>488</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.33.4.484</pub-id>, PMID: <pub-id pub-id-type="pmid">2729943</pub-id></citation></ref>
<ref id="ref52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Emami</surname> <given-names>S.</given-names></name> <name><surname>Tavangar</surname> <given-names>P.</given-names></name> <name><surname>Keighobadi</surname> <given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>An overview of azoles targeting sterol 14&#x03B1;-demethylase for antileishmanial therapy</article-title>. <source>Eur. J. Med. Chem.</source> <volume>135</volume>, <fpage>241</fpage>&#x2013;<lpage>259</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ejmech.2017.04.044</pub-id>, PMID: <pub-id pub-id-type="pmid">28456033</pub-id></citation></ref>
<ref id="ref53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Escobedo</surname> <given-names>A. A.</given-names></name> <name><surname>Lalle</surname> <given-names>M.</given-names></name> <name><surname>Hrastnik</surname> <given-names>N. I.</given-names></name> <name><surname>Rodr&#x00ED;guez-Morales</surname> <given-names>A. J.</given-names></name> <name><surname>Castro-S&#x00E1;nchez</surname> <given-names>E.</given-names></name> <name><surname>Cimerman</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Combination therapy in the management of giardiasis: what laboratory and clinical studies tell us, so far</article-title>. <source>Acta Trop.</source> <volume>162</volume>, <fpage>196</fpage>&#x2013;<lpage>205</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.actatropica.2016.06.026</pub-id>, PMID: <pub-id pub-id-type="pmid">27349189</pub-id></citation></ref>
<ref id="ref54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Farthing</surname> <given-names>M. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Treatment options for the eradication of intestinal protozoa</article-title>. <source>Nat. Clin. Pract. Gastroenterol. Hepatol.</source> <volume>3</volume>, <fpage>436</fpage>&#x2013;<lpage>445</lpage>. doi: <pub-id pub-id-type="doi">10.1038/ncpgasthep0557</pub-id>, PMID: <pub-id pub-id-type="pmid">16883348</pub-id></citation></ref>
<ref id="ref55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname> <given-names>M. C.</given-names></name> <name><surname>Da Silva</surname> <given-names>E. N.</given-names></name> <name><surname>Pinto</surname> <given-names>A. V.</given-names></name> <name><surname>De Castro</surname> <given-names>S. L.</given-names></name> <name><surname>Menna-Barreto</surname> <given-names>R. F.</given-names></name></person-group> (<year>2012</year>). <article-title>A novel triazolic naphthofuranquinone induces autophagy in reservosomes and impairment of mitosis in <italic>Trypanosoma cruzi</italic></article-title>. <source>Parasitology</source> <volume>139</volume>, <fpage>26</fpage>&#x2013;<lpage>36</lpage>. doi: <pub-id pub-id-type="doi">10.1017/S0031182011001612</pub-id>, PMID: <pub-id pub-id-type="pmid">21939585</pub-id></citation></ref>
<ref id="ref56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname> <given-names>R. I.</given-names></name></person-group> (<year>1993</year>). <article-title>Mechanism of action of hydroxychloroquine as an antirheumatic drug</article-title>. <source>Semin. Arthritis Rheum.</source> <volume>23</volume>, <fpage>82</fpage>&#x2013;<lpage>91</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0049-0172(10)80012-5</pub-id>, PMID: <pub-id pub-id-type="pmid">8278823</pub-id></citation></ref>
<ref id="ref57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fr&#x00E9;zard</surname> <given-names>F.</given-names></name> <name><surname>Demicheli</surname> <given-names>C.</given-names></name> <name><surname>Ribeiro</surname> <given-names>R. R.</given-names></name></person-group> (<year>2009</year>). <article-title>Pentavalent antimonials: new perspectives for old drugs</article-title>. <source>Molecules</source> <volume>14</volume>, <fpage>2317</fpage>&#x2013;<lpage>2336</lpage>. doi: <pub-id pub-id-type="doi">10.3390/molecules14072317</pub-id>, PMID: <pub-id pub-id-type="pmid">19633606</pub-id></citation></ref>
<ref id="ref58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gabay</surname> <given-names>T.</given-names></name> <name><surname>Krugliak</surname> <given-names>M.</given-names></name> <name><surname>Shalmiev</surname> <given-names>G.</given-names></name> <name><surname>Ginsburg</surname> <given-names>H.</given-names></name></person-group> (<year>1994</year>). <article-title>Inhibition by anti-malarial drugs of haemoglobin denaturation and iron release in acidified red blood cell lysates: a possible mechanism of their anti-malarial effect?</article-title> <source>Parasitology</source> <volume>108</volume>, <fpage>371</fpage>&#x2013;<lpage>381</lpage>. doi: <pub-id pub-id-type="doi">10.1017/S0031182000075910</pub-id>, PMID: <pub-id pub-id-type="pmid">8008450</pub-id></citation></ref>
<ref id="ref59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gachelin</surname> <given-names>G.</given-names></name> <name><surname>Garner</surname> <given-names>P.</given-names></name> <name><surname>Ferroni</surname> <given-names>E.</given-names></name> <name><surname>Verhave</surname> <given-names>J. P.</given-names></name> <name><surname>Opinel</surname> <given-names>A.</given-names></name></person-group> (<year>2018</year>). <article-title>Evidence and strategies for malaria prevention and control: a historical analysis</article-title>. <source>Malar. J.</source> <volume>17</volume>:<fpage>96</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12936-018-2244-2</pub-id>, PMID: <pub-id pub-id-type="pmid">29482556</pub-id></citation></ref>
<ref id="ref60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gaspar</surname> <given-names>L.</given-names></name> <name><surname>Moraes</surname> <given-names>C.</given-names></name> <name><surname>Freitas-Junior</surname> <given-names>L.</given-names></name> <name><surname>Ferrari</surname> <given-names>S.</given-names></name> <name><surname>Costantino</surname> <given-names>L.</given-names></name> <name><surname>Costi</surname> <given-names>M. P.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Current and future chemotherapy for Chagas disease</article-title>. <source>Curr. Med. Chem.</source> <volume>22</volume>, <fpage>4293</fpage>&#x2013;<lpage>4312</lpage>. doi: <pub-id pub-id-type="doi">10.2174/0929867322666151015120804</pub-id>, PMID: <pub-id pub-id-type="pmid">26477622</pub-id></citation></ref>
<ref id="ref61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname> <given-names>D.</given-names></name> <name><surname>Walton</surname> <given-names>J. L.</given-names></name> <name><surname>Roepe</surname> <given-names>P. D.</given-names></name> <name><surname>Sinai</surname> <given-names>A. P.</given-names></name></person-group> (<year>2012</year>). <article-title>Autophagy is a cell death mechanism in <italic>Toxoplasma gondii</italic></article-title>. <source>Cell. Microbiol.</source> <volume>14</volume>, <fpage>589</fpage>&#x2013;<lpage>607</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1462-5822.2011.01745.x</pub-id>, PMID: <pub-id pub-id-type="pmid">22212386</pub-id></citation></ref>
<ref id="ref62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x00E1;lez-Alcaide</surname> <given-names>G.</given-names></name> <name><surname>Peris</surname> <given-names>J.</given-names></name> <name><surname>Ramos</surname> <given-names>J. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Areas of research and clinical approaches to the study of liver abscess</article-title>. <source>World J. Gastroenterol.</source> <volume>23</volume>, <fpage>357</fpage>&#x2013;<lpage>365</lpage>. doi: <pub-id pub-id-type="doi">10.3748/wjg.v23.i2.357</pub-id>, PMID: <pub-id pub-id-type="pmid">28127209</pub-id></citation></ref>
<ref id="ref63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gopalakrishnan</surname> <given-names>A. M.</given-names></name> <name><surname>Kumar</surname> <given-names>N.</given-names></name></person-group> (<year>2015</year>). <article-title>Antimalarial action of artesunate involves DNA damage mediated by reactive oxygen species</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>59</volume>, <fpage>317</fpage>&#x2013;<lpage>325</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.03663-14</pub-id>, PMID: <pub-id pub-id-type="pmid">25348537</pub-id></citation></ref>
<ref id="ref64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Granthon</surname> <given-names>A. C.</given-names></name> <name><surname>Braga</surname> <given-names>M. V.</given-names></name> <name><surname>Rodrigues</surname> <given-names>J. C. F.</given-names></name> <name><surname>Cammerer</surname> <given-names>S.</given-names></name> <name><surname>Lorente</surname> <given-names>S. O.</given-names></name> <name><surname>Gilbert</surname> <given-names>I. H.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>Alterations on the growth and ultrastructure of <italic>Leishmania chagasi</italic> induced by squalene synthase inhibitors</article-title>. <source>Vet. Parasitol.</source> <volume>146</volume>, <fpage>25</fpage>&#x2013;<lpage>34</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.vetpar.2006.12.022</pub-id></citation></ref>
<ref id="ref65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herman</surname> <given-names>M.</given-names></name> <name><surname>Gillies</surname> <given-names>S.</given-names></name> <name><surname>Michels</surname> <given-names>P. A.</given-names></name> <name><surname>Rigden</surname> <given-names>D. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Autophagy and related processes in trypanosomatids: insights from genomic and bioinformatic analyses</article-title>. <source>Autophagy</source> <volume>2</volume>, <fpage>107</fpage>&#x2013;<lpage>118</lpage>. doi: <pub-id pub-id-type="doi">10.4161/auto.2.2.2369</pub-id></citation></ref>
<ref id="ref66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herman</surname> <given-names>M.</given-names></name> <name><surname>P&#x00E9;rez-Morga</surname> <given-names>D.</given-names></name> <name><surname>Schtickzelle</surname> <given-names>N.</given-names></name> <name><surname>Michels</surname> <given-names>P. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Turnover of glycosomes during life-cycle differentiation of <italic>Trypanosoma brucei</italic></article-title>. <source>Autophagy</source> <volume>4</volume>, <fpage>294</fpage>&#x2013;<lpage>308</lpage>. doi: <pub-id pub-id-type="doi">10.4161/auto.5443</pub-id></citation></ref>
<ref id="ref67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hern&#x00E1;ndez-Garc&#x00ED;a</surname> <given-names>M. S.</given-names></name> <name><surname>Miranda-Ozuna</surname> <given-names>J. F. T.</given-names></name> <name><surname>Salazar-Villatoro</surname> <given-names>L.</given-names></name> <name><surname>V&#x00E1;zquez-Calzada</surname> <given-names>C.</given-names></name> <name><surname>&#x00C1;vila-Gonz&#x00E1;lez</surname> <given-names>L.</given-names></name> <name><surname>Gonz&#x00E1;lez-Robles</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Biogenesis of autophagosome in <italic>Trichomonas vaginalis</italic> during macroautophagy induced by rapamycin-treatment and iron or glucose starvation conditions</article-title>. <source>J. Eukaryot. Microbiol.</source> <volume>66</volume>, <fpage>654</fpage>&#x2013;<lpage>669</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jeu.12712</pub-id>, PMID: <pub-id pub-id-type="pmid">30620421</pub-id></citation></ref>
<ref id="ref68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirt</surname> <given-names>R. P.</given-names></name></person-group> (<year>2013</year>). <article-title><italic>Trichomonas vaginalis</italic> virulence factors: an integrative overview</article-title>. <source>Sex. Transm. Infect.</source> <volume>89</volume>, <fpage>439</fpage>&#x2013;<lpage>443</lpage>. doi: <pub-id pub-id-type="doi">10.1136/sextrans-2013-051105</pub-id>, PMID: <pub-id pub-id-type="pmid">23694938</pub-id></citation></ref>
<ref id="ref69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname> <given-names>P. S.</given-names></name> <name><surname>Sisson</surname> <given-names>G.</given-names></name> <name><surname>Croxen</surname> <given-names>M. A.</given-names></name> <name><surname>Welch</surname> <given-names>K.</given-names></name> <name><surname>Harman</surname> <given-names>W. D.</given-names></name> <name><surname>Cremades</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of <italic>Helicobacter pylori</italic>, selected anaerobic bacteria and parasites, and <italic>Campylobacter jejuni</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>51</volume>, <fpage>868</fpage>&#x2013;<lpage>876</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.01159-06</pub-id>, PMID: <pub-id pub-id-type="pmid">17158936</pub-id></citation></ref>
<ref id="ref70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>K. Y.</given-names></name> <name><surname>Chen</surname> <given-names>R. M.</given-names></name> <name><surname>Lin</surname> <given-names>H. C.</given-names></name> <name><surname>Cheng</surname> <given-names>W. H.</given-names></name> <name><surname>Lin</surname> <given-names>H. A.</given-names></name> <name><surname>Lin</surname> <given-names>W. N.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Potential role of autophagy in proteolysis in <italic>Trichomonas vaginalis</italic></article-title>. <source>J. Microbiol. Immunol. Infect.</source> <volume>52</volume>, <fpage>336</fpage>&#x2013;<lpage>344</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jmii.2018.11.002</pub-id>, PMID: <pub-id pub-id-type="pmid">31859164</pub-id></citation></ref>
<ref id="ref71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaye</surname> <given-names>P.</given-names></name> <name><surname>Scott</surname> <given-names>P.</given-names></name></person-group> (<year>2011</year>). <article-title>Leishmaniasis: complexity at the host-pathogen interface</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>9</volume>, <fpage>604</fpage>&#x2013;<lpage>615</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrmicro2608</pub-id>, PMID: <pub-id pub-id-type="pmid">21747391</pub-id></citation></ref>
<ref id="ref72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname> <given-names>P. G. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)</article-title>. <source>Lancet Neurol.</source> <volume>12</volume>, <fpage>186</fpage>&#x2013;<lpage>194</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1474-4422(12)70296-X</pub-id>, PMID: <pub-id pub-id-type="pmid">23260189</pub-id></citation></ref>
<ref id="ref73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname> <given-names>P. G. E.</given-names></name> <name><surname>Rodgers</surname> <given-names>J.</given-names></name></person-group> (<year>2019</year>). <article-title>Clinical and neuropathogenetic aspects of human African trypanosomiasis</article-title>. <source>Front. Immunol.</source> <volume>10</volume>:<fpage>39</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2019.00039</pub-id>, PMID: <pub-id pub-id-type="pmid">30740102</pub-id></citation></ref>
<ref id="ref74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kiel</surname> <given-names>J. A. K. W.</given-names></name></person-group> (<year>2010</year>). <article-title>Autophagy in unicellular eukaryotes</article-title>. <source>Philos. Trans. R. Soc. Lond., B, Biol. Sci.</source> <volume>365</volume>, <fpage>819</fpage>&#x2013;<lpage>830</lpage>. doi: <pub-id pub-id-type="doi">10.1098/rstb.2009.0237</pub-id></citation></ref>
<ref id="ref75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kip</surname> <given-names>A. E.</given-names></name> <name><surname>Schellens</surname> <given-names>J. H. M.</given-names></name> <name><surname>Beijnen</surname> <given-names>J. H.</given-names></name> <name><surname>Dorlo</surname> <given-names>T. P. C.</given-names></name></person-group> (<year>2018</year>). <article-title>Clinical pharmacokinetics of systemically administered antileishmanial drugs</article-title>. <source>Clin. Pharmacokinet.</source> <volume>57</volume>, <fpage>151</fpage>&#x2013;<lpage>176</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s40262-017-0570-0</pub-id>, PMID: <pub-id pub-id-type="pmid">28756612</pub-id></citation></ref>
<ref id="ref76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kirkegaard</surname> <given-names>K.</given-names></name> <name><surname>Taylor</surname> <given-names>M. P.</given-names></name> <name><surname>Jackson</surname> <given-names>W. T.</given-names></name></person-group> (<year>2004</year>). <article-title>Cellular autophagy: surrender, avoidance and subversion by microorganisms</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>2</volume>, <fpage>301</fpage>&#x2013;<lpage>314</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrmicro865</pub-id>, PMID: <pub-id pub-id-type="pmid">15031729</pub-id></citation></ref>
<ref id="ref77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kitamura</surname> <given-names>K.</given-names></name> <name><surname>Kishi-Itakura</surname> <given-names>C.</given-names></name> <name><surname>Tsuboi</surname> <given-names>T.</given-names></name> <name><surname>Sato</surname> <given-names>S.</given-names></name> <name><surname>Kita</surname> <given-names>K.</given-names></name> <name><surname>Ohta</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Autophagy-related Atg8 localizes to the apicoplast of the human malaria parasite <italic>Plasmodium falciparum</italic></article-title>. <source>PLoS One</source> <volume>7</volume>:<fpage>e42977</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0042977</pub-id>, PMID: <pub-id pub-id-type="pmid">22900071</pub-id></citation></ref>
<ref id="ref78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klionsky</surname> <given-names>D. J.</given-names></name> <name><surname>Abdel-Aziz</surname> <given-names>A. K.</given-names></name> <name><surname>Abdelfatah</surname> <given-names>S.</given-names></name> <name><surname>Abdellatif</surname> <given-names>M.</given-names></name> <name><surname>Abdoli</surname> <given-names>A.</given-names></name> <name><surname>Abel</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)</article-title>. <source>Autophagy</source> <volume>17</volume>, <fpage>1</fpage>&#x2013;<lpage>382</lpage>. doi: <pub-id pub-id-type="doi">10.1080/15548627.2020.1797280</pub-id>, PMID: <pub-id pub-id-type="pmid">22966490</pub-id></citation></ref>
<ref id="ref79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klionsky</surname> <given-names>D. J.</given-names></name> <name><surname>Cregg</surname> <given-names>J. M.</given-names></name> <name><surname>Dunn</surname> <given-names>W. A.</given-names></name> <name><surname>Emr</surname> <given-names>S. D.</given-names></name> <name><surname>Sakai</surname> <given-names>Y.</given-names></name> <name><surname>Sandoval</surname> <given-names>I. V.</given-names></name> <etal/></person-group>. (<year>2003</year>). <article-title>A unified nomenclature for yeast autophagy-related genes</article-title>. <source>Dev. Cell</source> <volume>5</volume>, <fpage>539</fpage>&#x2013;<lpage>545</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1534-5807(03)00296-X</pub-id>, PMID: <pub-id pub-id-type="pmid">14536056</pub-id></citation></ref>
<ref id="ref80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname> <given-names>H. X.</given-names></name> <name><surname>Aye</surname> <given-names>H. M.</given-names></name> <name><surname>Tan</surname> <given-names>K. S. W.</given-names></name> <name><surname>He</surname> <given-names>C. Y.</given-names></name></person-group> (<year>2015</year>). <article-title>The lysosomotropic drug LeuLeu-OMe induces lysosome disruption and autophagy-independent cell death in <italic>Trypanosoma brucei</italic></article-title>. <source>Microb. Cell</source> <volume>2</volume>, <fpage>288</fpage>&#x2013;<lpage>298</lpage>. doi: <pub-id pub-id-type="doi">10.15698/mic2015.08.217</pub-id>, PMID: <pub-id pub-id-type="pmid">28357304</pub-id></citation></ref>
<ref id="ref81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kong-Hap</surname> <given-names>M. A.</given-names></name> <name><surname>Mouammine</surname> <given-names>A.</given-names></name> <name><surname>Daher</surname> <given-names>W.</given-names></name> <name><surname>Berry</surname> <given-names>L.</given-names></name> <name><surname>Lebrun</surname> <given-names>M.</given-names></name> <name><surname>Dubremetz</surname> <given-names>J. F.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Regulation of ATG8 membrane association by ATG4 in the parasitic protist <italic>Toxoplasma gondii</italic></article-title>. <source>Autophagy</source> <volume>9</volume>, <fpage>1334</fpage>&#x2013;<lpage>1348</lpage>. doi: <pub-id pub-id-type="doi">10.4161/auto.25189</pub-id></citation></ref>
<ref id="ref82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koopmann</surname> <given-names>R.</given-names></name> <name><surname>Muhammad</surname> <given-names>K.</given-names></name> <name><surname>Perbandt</surname> <given-names>M.</given-names></name> <name><surname>Betzel</surname> <given-names>C.</given-names></name> <name><surname>Duszenko</surname> <given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Trypanosoma brucei ATG8: structural insights into autophagic-like mechanisms in protozoa</article-title>. <source>Autophagy</source> <volume>5</volume>, <fpage>1085</fpage>&#x2013;<lpage>1091</lpage>. doi: <pub-id pub-id-type="doi">10.4161/auto.5.8.9611</pub-id></citation></ref>
<ref id="ref83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lavine</surname> <given-names>M. D.</given-names></name> <name><surname>Arrizabalaga</surname> <given-names>G.</given-names></name></person-group> (<year>2012</year>). <article-title>Analysis of monensin sensitivity in <italic>Toxoplasma gondii</italic> reveals autophagy as a mechanism for drug induced death</article-title>. <source>PLoS One</source> <volume>7</volume>:<fpage>e42107</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0042107</pub-id>, PMID: <pub-id pub-id-type="pmid">22848721</pub-id></citation></ref>
<ref id="ref84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lazarin-Bid&#x00F3;ia</surname> <given-names>D.</given-names></name> <name><surname>Desoti</surname> <given-names>V. C.</given-names></name> <name><surname>Ueda-Nakamura</surname> <given-names>T.</given-names></name> <name><surname>Dias Filho</surname> <given-names>B. P.</given-names></name> <name><surname>Nakamura</surname> <given-names>C. V.</given-names></name> <name><surname>Silva</surname> <given-names>S. O.</given-names></name></person-group> (<year>2013</year>). <article-title>Further evidence of the trypanocidal action of eupomatenoid-5: confirmation of involvement of reactive oxygen species and mitochondria owing to a reduction in trypanothione reductase activity</article-title>. <source>Free Radic. Biol. Med.</source> <volume>60</volume>, <fpage>17</fpage>&#x2013;<lpage>28</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2013.01.008</pub-id>, PMID: <pub-id pub-id-type="pmid">23376033</pub-id></citation></ref>
<ref id="ref85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>N.</given-names></name> <name><surname>Bertholet</surname> <given-names>S.</given-names></name> <name><surname>Debrabant</surname> <given-names>A.</given-names></name> <name><surname>Muller</surname> <given-names>J.</given-names></name> <name><surname>Duncan</surname> <given-names>R.</given-names></name> <name><surname>Nakhasi</surname> <given-names>H. L.</given-names></name></person-group> (<year>2002</year>). <article-title>Programmed cell death in the unicellular protozoan parasite <italic>Leishmania</italic></article-title>. <source>Cell Death Differ.</source> <volume>9</volume>, <fpage>53</fpage>&#x2013;<lpage>64</lpage>. doi: <pub-id pub-id-type="doi">10.1038/sj.cdd.4400952</pub-id>, PMID: <pub-id pub-id-type="pmid">11803374</pub-id></citation></ref>
<ref id="ref86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leitsch</surname> <given-names>D.</given-names></name> <name><surname>Schlosser</surname> <given-names>S.</given-names></name> <name><surname>Burgess</surname> <given-names>A.</given-names></name> <name><surname>Duchene</surname> <given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Nitroimidazole drugs vary in their mode of action in the human parasite <italic>Giardia lamblia</italic></article-title>. <source>Int. J. Parasitol. Drugs Drug Resist.</source> <volume>2</volume>, <fpage>166</fpage>&#x2013;<lpage>170</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijpddr.2012.04.002</pub-id>, PMID: <pub-id pub-id-type="pmid">24533278</pub-id></citation></ref>
<ref id="ref87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname> <given-names>A. K. C.</given-names></name> <name><surname>Leung</surname> <given-names>A. A. M.</given-names></name> <name><surname>Wong</surname> <given-names>A. H. C.</given-names></name> <name><surname>Sergi</surname> <given-names>C. M.</given-names></name> <name><surname>Kam</surname> <given-names>J. K. M.</given-names></name></person-group> (<year>2019</year>). <article-title>Giardiasis: an overview</article-title>. <source>Recent Patents Inflamm. Allergy Drug Discov.</source> <volume>13</volume>, <fpage>134</fpage>&#x2013;<lpage>143</lpage>. doi: <pub-id pub-id-type="doi">10.2174/1872213X13666190618124901</pub-id>, PMID: <pub-id pub-id-type="pmid">33681490</pub-id></citation></ref>
<ref id="ref88"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>L&#x00E9;v&#x00EA;que</surname> <given-names>M. F.</given-names></name> <name><surname>Berry</surname> <given-names>L.</given-names></name> <name><surname>Cipriano</surname> <given-names>M. J.</given-names></name> <name><surname>Nguyen</surname> <given-names>H. M.</given-names></name> <name><surname>Striepen</surname> <given-names>B.</given-names></name> <name><surname>Besteiro</surname> <given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Autophagy-related protein ATG8 has a noncanonical function for apicoplast inheritance in <italic>Toxoplasma gondii</italic></article-title>. <source>MBio</source> <volume>6</volume>, <fpage>e01446</fpage>&#x2013;<lpage>e01415</lpage>. doi: <pub-id pub-id-type="doi">10.1128/mBio.01446-15</pub-id>, PMID: <pub-id pub-id-type="pmid">26507233</pub-id></citation></ref>
<ref id="ref89"><citation citation-type="book"><person-group person-group-type="author"><name><surname>L&#x00E9;v&#x00EA;que</surname> <given-names>M.</given-names></name> <name><surname>Besteiro</surname> <given-names>S.</given-names></name></person-group> (<year>2016</year>). &#x201C;<article-title>Unusual functions for the autophagy machinery in apicomplexan parasites,</article-title>&#x201D; in <source>Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging.</source> ed. <person-group person-group-type="editor"><name><surname>Hayat</surname> <given-names>M. A.</given-names></name></person-group> (<publisher-loc>Massachusetts, EUA</publisher-loc>: <publisher-name>Academic Press</publisher-name>), <fpage>281</fpage>&#x2013;<lpage>292</lpage>.</citation></ref>
<ref id="ref90"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname> <given-names>B.</given-names></name> <name><surname>Yuan</surname> <given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>Autophagy in cell death: an innocent convict?</article-title> <source>J. Clin. Invest.</source> <volume>115</volume>, <fpage>2679</fpage>&#x2013;<lpage>2688</lpage>. doi: <pub-id pub-id-type="doi">10.1172/JCI26390</pub-id>, PMID: <pub-id pub-id-type="pmid">16200202</pub-id></citation></ref>
<ref id="ref91"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>F. J.</given-names></name> <name><surname>He</surname> <given-names>C. Y.</given-names></name></person-group> (<year>2014</year>). <article-title>Acidocalcisome is required for autophagy in <italic>Trypanosoma brucei</italic></article-title>. <source>Autophagy</source> <volume>10</volume>, <fpage>1978</fpage>&#x2013;<lpage>1988</lpage>. doi: <pub-id pub-id-type="doi">10.4161/auto.36183</pub-id>, PMID: <pub-id pub-id-type="pmid">25484093</pub-id></citation></ref>
<ref id="ref92"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>F. J.</given-names></name> <name><surname>He</surname> <given-names>C. Y.</given-names></name></person-group> (<year>2017</year>). <article-title>Autophagy in protozoan parasites: <italic>Trypanosoma brucei</italic> as a model</article-title>. <source>Future Microbiol.</source> <volume>12</volume>, <fpage>1337</fpage>&#x2013;<lpage>1340</lpage>. doi: <pub-id pub-id-type="doi">10.2217/fmb-2017-0158</pub-id>, PMID: <pub-id pub-id-type="pmid">28972412</pub-id></citation></ref>
<ref id="ref93"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname> <given-names>K. T.</given-names></name> <name><surname>Amanah</surname> <given-names>A.</given-names></name> <name><surname>Chear</surname> <given-names>N. J. Y.</given-names></name> <name><surname>Zahari</surname> <given-names>Z.</given-names></name> <name><surname>Zainuddin</surname> <given-names>Z.</given-names></name> <name><surname>Adenan</surname> <given-names>M. I.</given-names></name></person-group> (<year>2018</year>). <article-title>Inhibitory effects of (+)-spectaline and iso-6-spectaline from <italic>Senna spectabilis</italic> on the growth and ultrastructure of human-infective species <italic>Trypanosoma brucei</italic> rhodesiense bloodstream form</article-title>. <source>Exp. Parasitol.</source> <volume>184</volume>, <fpage>57</fpage>&#x2013;<lpage>66</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.exppara.2017.11.007</pub-id>, PMID: <pub-id pub-id-type="pmid">29175017</pub-id></citation></ref>
<ref id="ref94"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindmark</surname> <given-names>D. G.</given-names></name> <name><surname>M&#x00FC;ller</surname> <given-names>M.</given-names></name></person-group> (<year>1976</year>). <article-title>Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>10</volume>, <fpage>476</fpage>&#x2013;<lpage>482</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.10.3.476</pub-id>, PMID: <pub-id pub-id-type="pmid">791102</pub-id></citation></ref>
<ref id="ref95"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>LoGiudice</surname> <given-names>N.</given-names></name> <name><surname>Le</surname> <given-names>L.</given-names></name> <name><surname>Abuan</surname> <given-names>I.</given-names></name> <name><surname>Leizorek</surname> <given-names>Y.</given-names></name> <name><surname>Roberts</surname> <given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Alpha-difluoromethylornithine, an irreversible inhibitor of polyamine biosynthesis, as a therapeutic strategy against hyperproliferative and infectious diseases</article-title>. <source>Med. Sci.</source> <volume>6</volume>:<fpage>12</fpage>. doi: <pub-id pub-id-type="doi">10.3390/medsci6010012</pub-id>, PMID: <pub-id pub-id-type="pmid">29419804</pub-id></citation></ref>
<ref id="ref96"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Losinno</surname> <given-names>A. D.</given-names></name> <name><surname>Mart&#x00ED;nez</surname> <given-names>S. J.</given-names></name> <name><surname>Labriola</surname> <given-names>C. A.</given-names></name> <name><surname>Carrillo</surname> <given-names>C.</given-names></name> <name><surname>Romano</surname> <given-names>P. S.</given-names></name></person-group> (<year>2021</year>). <article-title>Induction of autophagy increases the proteolytic activity of reservosomes during <italic>Trypanosoma cruzi</italic> metacyclogenesis</article-title>. <source>Autophagy</source> <volume>17</volume>, <fpage>439</fpage>&#x2013;<lpage>456</lpage>. doi: <pub-id pub-id-type="doi">10.1080/15548627.2020.1720428</pub-id>, PMID: <pub-id pub-id-type="pmid">31983275</pub-id></citation></ref>
<ref id="ref97"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luque-Ortega</surname> <given-names>J. R.</given-names></name> <name><surname>Rivas</surname> <given-names>L.</given-names></name></person-group> (<year>2007</year>). <article-title>Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in <italic>Leishmania donovani</italic> promastigotes</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>51</volume>, <fpage>1327</fpage>&#x2013;<lpage>1332</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.01415-06</pub-id>, PMID: <pub-id pub-id-type="pmid">17283192</pub-id></citation></ref>
<ref id="ref98"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Macedo-Silva</surname> <given-names>S. T.</given-names></name> <name><surname>Oliveira Silva</surname> <given-names>T. L. A.</given-names></name> <name><surname>Urbina</surname> <given-names>J. A.</given-names></name> <name><surname>de Souza</surname> <given-names>W.</given-names></name> <name><surname>Rodrigues</surname> <given-names>J. C.</given-names></name></person-group> (<year>2011</year>). <article-title>Antiproliferative, ultrastructural, and physiological effects of amiodarone on promastigote and amastigote forms of <italic>Leishmania amazonensis</italic></article-title>. <source>Mol. Biol. Int.</source> <volume>2011</volume>:<fpage>876021</fpage>. doi: <pub-id pub-id-type="doi">10.4061/2011/876021</pub-id>, PMID: <pub-id pub-id-type="pmid">22091415</pub-id></citation></ref>
<ref id="ref99"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maia</surname> <given-names>C.</given-names></name> <name><surname>Attias</surname> <given-names>M.</given-names></name> <name><surname>Urbina</surname> <given-names>J.</given-names></name> <name><surname>Gilbert</surname> <given-names>I.</given-names></name> <name><surname>Magaraci</surname> <given-names>F.</given-names></name> <name><surname>de Souza</surname> <given-names>W.</given-names></name></person-group> (<year>2007</year>). <article-title>Azasterols impair <italic>Giardia lamblia</italic> proliferation and induces encystation</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>363</volume>, <fpage>310</fpage>&#x2013;<lpage>316</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbrc.2007.08.174</pub-id>, PMID: <pub-id pub-id-type="pmid">17870055</pub-id></citation></ref>
<ref id="ref100"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x00ED;nez-Garc&#x00ED;a</surname> <given-names>M.</given-names></name> <name><surname>Bart</surname> <given-names>J. M.</given-names></name> <name><surname>Campos-Salinas</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Autophagic-related cell death of <italic>Trypanosoma brucei</italic> induced by bacteriocin AS-48</article-title>. <source>Int. J. Parasitol. Drugs Drug Resist.</source> <volume>8</volume>, <fpage>203</fpage>&#x2013;<lpage>212</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijpddr.2018.03.002</pub-id>, PMID: <pub-id pub-id-type="pmid">29649664</pub-id></citation></ref>
<ref id="ref101"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martins-Duarte</surname> <given-names>E. S.</given-names></name> <name><surname>Jones</surname> <given-names>S. M.</given-names></name> <name><surname>Gilbert</surname> <given-names>I. H.</given-names></name> <name><surname>Atella</surname> <given-names>G. C.</given-names></name> <name><surname>de Souza</surname> <given-names>W.</given-names></name> <name><surname>Vommaro</surname> <given-names>R. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Thiolactomycin analogues as potential anti-<italic>Toxoplasma gondii</italic> agents</article-title>. <source>Parasitol. Int.</source> <volume>58</volume>, <fpage>411</fpage>&#x2013;<lpage>415</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.parint.2009.08.004</pub-id>, PMID: <pub-id pub-id-type="pmid">19698800</pub-id></citation></ref>
<ref id="ref102"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mbacham</surname> <given-names>W. F.</given-names></name> <name><surname>Ayong</surname> <given-names>L.</given-names></name> <name><surname>Guewo-Fokeng</surname> <given-names>M.</given-names></name> <name><surname>Makoge</surname> <given-names>V.</given-names></name></person-group> (<year>2019</year>). <article-title>Current situation of malaria in Africa. Malaria control and elimination</article-title>. <source>Methods Mol. Biol.</source> <volume>2013</volume>, <fpage>29</fpage>&#x2013;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-1-4939-9550-9_2</pub-id></citation></ref>
<ref id="ref103"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Menna-Barreto</surname> <given-names>R. F. S.</given-names></name></person-group> (<year>2019</year>). <article-title>Cell death pathways in pathogenic trypanosomatids: lessons of (over)kill</article-title>. <source>Cell Death Dis.</source> <volume>30</volume>:<fpage>93</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41419-019-1370-2</pub-id></citation></ref>
<ref id="ref104"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Menna-Barreto</surname> <given-names>R. F. S.</given-names></name> <name><surname>Corr&#x00EA;a</surname> <given-names>J. R.</given-names></name> <name><surname>Cascabulho</surname> <given-names>C. M.</given-names></name> <name><surname>Fernandes</surname> <given-names>M. C.</given-names></name> <name><surname>Pinto</surname> <given-names>A. V.</given-names></name> <name><surname>Soares</surname> <given-names>M. J.</given-names></name> <etal/></person-group>. (<year>2009a</year>). <article-title>Naphthoimidazoles promote different death phenotypes in <italic>Trypanosoma cruzi</italic></article-title>. <source>Parasitology</source> <volume>136</volume>, <fpage>499</fpage>&#x2013;<lpage>510</lpage>. doi: <pub-id pub-id-type="doi">10.1017/S0031182009005745</pub-id></citation></ref>
<ref id="ref105"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Menna-Barreto</surname> <given-names>R. F. S. R.</given-names></name> <name><surname>De Castro</surname> <given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Clear shot at primary aim: susceptibility of <italic>Trypanosoma cruzi</italic> organelles, structures and molecular targets to drug treatment</article-title>. <source>Curr. Top. Med. Chem.</source> <volume>17</volume>, <fpage>1212</fpage>&#x2013;<lpage>1234</lpage>. doi: <pub-id pub-id-type="doi">10.2174/1568026616666161025161858</pub-id></citation></ref>
<ref id="ref106"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Menna-Barreto</surname> <given-names>R. F. S.</given-names></name> <name><surname>Goncalves</surname> <given-names>R. L. S.</given-names></name> <name><surname>Costa</surname> <given-names>E. M.</given-names></name> <name><surname>Silva</surname> <given-names>R. S.</given-names></name> <name><surname>Pinto</surname> <given-names>A. V.</given-names></name> <name><surname>Oliveira</surname> <given-names>M. F.</given-names></name> <etal/></person-group>. (<year>2009b</year>). <article-title>The effects on <italic>Trypanosoma cruzi</italic> of novel synthetic naphthoquinones are mediated by mitochondrial dysfunction</article-title>. <source>Free Radic. Biol. Med.</source> <volume>47</volume>, <fpage>644</fpage>&#x2013;<lpage>653</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2009.06.004</pub-id></citation></ref>
<ref id="ref107"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Menna-Barreto</surname> <given-names>R. F. S.</given-names></name> <name><surname>Salom&#x00E3;o</surname> <given-names>K.</given-names></name> <name><surname>Dantas</surname> <given-names>A. P.</given-names></name> <name><surname>Santa-Rita</surname> <given-names>R. M.</given-names></name> <name><surname>Soares</surname> <given-names>M. J.</given-names></name> <name><surname>Barbosa</surname> <given-names>H. S.</given-names></name> <etal/></person-group>. (<year>2009c</year>). <article-title>Different cell death pathways induced by drugs in <italic>Trypanosoma cruzi</italic>: an ultrastructural study</article-title>. <source>Micron</source> <volume>40</volume>, <fpage>157</fpage>&#x2013;<lpage>168</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.micron.2008.08.003</pub-id></citation></ref>
<ref id="ref108"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname> <given-names>J.</given-names></name> <name><surname>Rout</surname> <given-names>S.</given-names></name> <name><surname>Leitsch</surname> <given-names>D.</given-names></name> <name><surname>Vaithilingam</surname> <given-names>J.</given-names></name> <name><surname>Hehl</surname> <given-names>A.</given-names></name> <name><surname>Muller</surname> <given-names>N.</given-names></name></person-group> (<year>2015</year>). <article-title>Comparative characterisation of two nitroreductases from <italic>Giardia lamblia</italic> as potential activators of nitro compounds</article-title>. <source>Int. J. Parasitol. Drugs Drug Resist.</source> <volume>5</volume>, <fpage>37</fpage>&#x2013;<lpage>43</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijpddr.2015.03.001</pub-id>, PMID: <pub-id pub-id-type="pmid">27099829</pub-id></citation></ref>
<ref id="ref109"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mungthin</surname> <given-names>M.</given-names></name> <name><surname>Bray</surname> <given-names>P. G.</given-names></name> <name><surname>Ridley</surname> <given-names>R. G.</given-names></name> <name><surname>Ward</surname> <given-names>S. A.</given-names></name></person-group> (<year>1998</year>). <article-title>Central role of hemoglobin degradation in mechanisms of action of 4-amino- quinolines, quinoline methanols, and phenanthrene methanols</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>42</volume>, <fpage>2973</fpage>&#x2013;<lpage>2977</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.42.11.2973</pub-id>, PMID: <pub-id pub-id-type="pmid">9797235</pub-id></citation></ref>
<ref id="ref110"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname> <given-names>H. M.</given-names></name> <name><surname>Berry</surname> <given-names>L.</given-names></name> <name> <surname>Sullivan</surname> <given-names>W. J.</given-names> <suffix>Jr.</suffix></name> <name><surname>Besteiro</surname> <given-names>S.</given-names></name></person-group> (<year>2017a</year>). <article-title>Autophagy participates in the unfolded protein response in <italic>Toxoplasma gondii</italic></article-title>. <source>FEMS Microbiol. Lett.</source> <volume>364</volume>:<fpage>fnx153</fpage>. doi: <pub-id pub-id-type="doi">10.1093/femsle/fnx153</pub-id></citation></ref>
<ref id="ref111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname> <given-names>H. M.</given-names></name> <name><surname>El Hajj</surname> <given-names>H.</given-names></name> <name><surname>El Hajj</surname> <given-names>R.</given-names></name> <name><surname>Tawil</surname> <given-names>N.</given-names></name> <name><surname>Berry</surname> <given-names>L.</given-names></name> <name><surname>Lebrun</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2017b</year>). <article-title><italic>Toxoplasma gondii</italic> autophagy-related protein ATG9 is crucial for the survival of parasites in their host</article-title>. <source>Cell. Microbiol.</source> <volume>19</volume>:<fpage>e12712</fpage>. doi: <pub-id pub-id-type="doi">10.1111/cmi.12712</pub-id>, PMID: <pub-id pub-id-type="pmid">27992947</pub-id></citation></ref>
<ref id="ref112"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nishi</surname> <given-names>L.</given-names></name> <name><surname>Sanfelice</surname> <given-names>R.</given-names></name> <name><surname>Bortoleti</surname> <given-names>B.</given-names></name> <name><surname>Tomiotto-Pellissier</surname> <given-names>F.</given-names></name> <name><surname>Silva</surname> <given-names>T. F.</given-names></name> <name><surname>Evangelista</surname> <given-names>F. F.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title><italic>Moringa oleifera</italic> extract promotes apoptosis-like death in <italic>Toxoplasma gondii</italic> tachyzoites <italic>in vitro</italic></article-title>. <source>Parasitology</source> <volume>148</volume>, <fpage>1447</fpage>&#x2013;<lpage>1457</lpage>. doi: <pub-id pub-id-type="doi">10.1017/S0031182021001086</pub-id></citation></ref>
<ref id="ref113"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Painter</surname> <given-names>H. J.</given-names></name> <name><surname>Morrisey</surname> <given-names>J. M.</given-names></name> <name><surname>Vaidya</surname> <given-names>A. B.</given-names></name></person-group> (<year>2010</year>). <article-title>Mitochondrial electron transport inhibition and viability of intraerythrocytic <italic>Plasmodium falciparum</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>54</volume>, <fpage>5281</fpage>&#x2013;<lpage>5287</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.00937-10</pub-id>, PMID: <pub-id pub-id-type="pmid">20855748</pub-id></citation></ref>
<ref id="ref114"><citation citation-type="other"><person-group person-group-type="author"><collab id="coll6">Pan American Health Organization</collab></person-group> (<year>2019</year>). Manual of Procedures for Surveillance and Control of Leishmaniasis in the Americas. Available at: <ext-link xlink:href="https://iris.paho.org/handle/10665.2/51838" ext-link-type="uri">https://iris.paho.org/handle/10665.2/51838</ext-link> (Accessed August 15, 2021).</citation></ref>
<ref id="ref115"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pasquier</surname> <given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>Autophagy inhibitors</article-title>. <source>Cell. Mol. Life Sci.</source> <volume>73</volume>, <fpage>985</fpage>&#x2013;<lpage>1001</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00018-015-2104-y</pub-id>, PMID: <pub-id pub-id-type="pmid">26658914</pub-id></citation></ref>
<ref id="ref116"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pedra-Rezende</surname> <given-names>Y.</given-names></name> <name><surname>Fernandes</surname> <given-names>M. C.</given-names></name> <name><surname>Mesquita-Rodrigues</surname> <given-names>C.</given-names></name> <name><surname>Stiebler</surname> <given-names>R.</given-names></name> <name><surname>Bomba&#x00E7;a</surname> <given-names>A. C. S.</given-names></name> <name><surname>Pinho</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Starvation and pH stress conditions induced mitochondrial dysfunction, ROS production and autophagy in <italic>Trypanosoma cruzi</italic> epimastigotes</article-title>. <source>Biochim. Biophys. Acta Mol. basis Dis.</source> <volume>1867</volume>:<fpage>166028</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbadis.2020.166028</pub-id>, PMID: <pub-id pub-id-type="pmid">33248274</pub-id></citation></ref>
<ref id="ref117"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pe&#x00F1;a</surname> <given-names>I.</given-names></name> <name><surname>Pilar Manzano</surname> <given-names>M.</given-names></name> <name><surname>Cantizani</surname> <given-names>J.</given-names></name> <name><surname>Kessler</surname> <given-names>A.</given-names></name> <name><surname>Alonso-Padilla</surname> <given-names>J.</given-names></name> <name><surname>Bardera</surname> <given-names>A. I.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource</article-title>. <source>Sci. Rep.</source> <volume>5</volume>:<fpage>8771</fpage>. doi: <pub-id pub-id-type="doi">10.1038/srep08771</pub-id>, PMID: <pub-id pub-id-type="pmid">25740547</pub-id></citation></ref>
<ref id="ref118"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Picazarri</surname> <given-names>K.</given-names></name> <name><surname>Nakada-Tsukui</surname> <given-names>K.</given-names></name> <name><surname>Tsuboi</surname> <given-names>K.</given-names></name> <name><surname>Miyamoto</surname> <given-names>E.</given-names></name> <name><surname>Watanabe</surname> <given-names>N.</given-names></name> <name><surname>Kawakami</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Atg8 is involved in endosomal and phagosomal acidification in the parasitic protist <italic>Entamoeba histolytica</italic></article-title>. <source>Cell. Microbiol.</source> <volume>17</volume>, <fpage>1510</fpage>&#x2013;<lpage>1522</lpage>. doi: <pub-id pub-id-type="doi">10.1111/cmi.12453</pub-id>, PMID: <pub-id pub-id-type="pmid">25923949</pub-id></citation></ref>
<ref id="ref119"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Proto</surname> <given-names>W. R.</given-names></name> <name><surname>Coombs</surname> <given-names>G. H.</given-names></name> <name><surname>Mottram</surname> <given-names>J. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Cell death in parasitic protozoa: regulated or incidental?</article-title> <source>Nat. Rev. Microbiol.</source> <volume>11</volume>, <fpage>58</fpage>&#x2013;<lpage>66</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrmicro2929</pub-id>, PMID: <pub-id pub-id-type="pmid">23202528</pub-id></citation></ref>
<ref id="ref120"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rassi</surname> <given-names>A.</given-names></name> <name><surname>Rassi</surname> <given-names>A.</given-names></name> <name><surname>Marin-Neto</surname> <given-names>J. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Chagas disease</article-title>. <source>Lancet</source> <volume>375</volume>, <fpage>1388</fpage>&#x2013;<lpage>1402</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(10)60061-X</pub-id>, PMID: <pub-id pub-id-type="pmid">20399979</pub-id></citation></ref>
<ref id="ref121"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rigden</surname> <given-names>D. J.</given-names></name> <name><surname>Herman</surname> <given-names>M.</given-names></name> <name><surname>Gillies</surname> <given-names>S.</given-names></name> <name><surname>Michels</surname> <given-names>P. A.</given-names></name></person-group> (<year>2005</year>). <article-title>Implications of a genomic search for autophagy-related genes in trypanosomatids</article-title>. <source>Biochem. Soc. Trans.</source> <volume>33</volume>, <fpage>972</fpage>&#x2013;<lpage>974</lpage>. doi: <pub-id pub-id-type="doi">10.1042/BST0330972</pub-id>, PMID: <pub-id pub-id-type="pmid">16246023</pub-id></citation></ref>
<ref id="ref122"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roatt</surname> <given-names>B. M.</given-names></name> <name><surname>de Oliveira</surname> <given-names>C. J. M.</given-names></name> <name><surname>De Brito</surname> <given-names>R. C. F.</given-names></name> <name><surname>Coura-Vital</surname> <given-names>W.</given-names></name> <name><surname>de Oliveira Aguiar-Soares</surname> <given-names>R. D.</given-names></name> <name><surname>Reis</surname> <given-names>A. B.</given-names></name></person-group> (<year>2020</year>). <article-title>Recent advances and new strategies on leishmaniasis treatment</article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>104</volume>, <fpage>8965</fpage>&#x2013;<lpage>8977</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00253-020-10856-w</pub-id>, PMID: <pub-id pub-id-type="pmid">32875362</pub-id></citation></ref>
<ref id="ref123"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rogawski</surname> <given-names>E. T.</given-names></name> <name><surname>Bartelt</surname> <given-names>L. A.</given-names></name> <name><surname>Platts-Mills</surname> <given-names>J. A.</given-names></name> <name><surname>Seidman</surname> <given-names>J. C.</given-names></name> <name><surname>Samie</surname> <given-names>A.</given-names></name> <name><surname>Havt</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Determinants and impact of giardia infection in the first 2 years of life in the MAL-ED birth cohort</article-title>. <source>J. Pediatr. Infect. Dis. Soc.</source> <volume>6</volume>, <fpage>153</fpage>&#x2013;<lpage>160</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jpids/piw082</pub-id></citation></ref>
<ref id="ref124"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rowley</surname> <given-names>J.</given-names></name> <name><surname>Hoorn</surname> <given-names>S. V.</given-names></name> <name><surname>Korenromp</surname> <given-names>E.</given-names></name> <name><surname>Low</surname> <given-names>N.</given-names></name> <name><surname>Unemo</surname> <given-names>M.</given-names></name> <name><surname>Abu-Raddad</surname> <given-names>L. J.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016</article-title>. <source>Bull. World Health Organ.</source> <volume>97</volume>, <fpage>548</fpage>&#x2013;<lpage>562</lpage>. doi: <pub-id pub-id-type="doi">10.2471/BLT.18.228486</pub-id>, PMID: <pub-id pub-id-type="pmid">31384073</pub-id></citation></ref>
<ref id="ref125"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scariot</surname> <given-names>D. B.</given-names></name> <name><surname>Britta</surname> <given-names>E. A.</given-names></name> <name><surname>Moreira</surname> <given-names>A. L.</given-names></name> <name><surname>Falzirolli</surname> <given-names>H.</given-names></name> <name><surname>Silva</surname> <given-names>C. C.</given-names></name> <name><surname>Ueda-Nakamura</surname> <given-names>T.</given-names></name></person-group> (<year>2017</year>). <article-title>Induction of early autophagic process on <italic>Leishmania amazonensis</italic> by synergistic effect of miltefosine and innovative semi-synthetic thiosemicarbazone</article-title>. <source>Front. Microbiol.</source> <volume>8</volume>:<fpage>255</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2017.00255</pub-id>, PMID: <pub-id pub-id-type="pmid">28270805</pub-id></citation></ref>
<ref id="ref500"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scariot</surname> <given-names>D. B.</given-names></name> <name><surname>Volpato</surname> <given-names>H.</given-names></name> <name><surname>Fernandes</surname> <given-names>N. S.</given-names></name> <name><surname>Soares</surname> <given-names>E. F. P.</given-names></name> <name><surname>Ueda-Nakamura</surname> <given-names>T.</given-names></name> <name><surname>Dias-Filho</surname> <given-names>B. P.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Activity and cell-death pathway in <italic>Leishmania infantum</italic> induced by sugiol: vectorization using yeast cell wall particles obtained from <italic>saccharomyces cerevisiae</italic></article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>9</volume>:<lpage>208</lpage>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2019.00208</pub-id>, PMID: <pub-id pub-id-type="pmid">20855728</pub-id></citation></ref>
<ref id="ref126"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schoijet</surname> <given-names>A. C.</given-names></name> <name><surname>Sternlieb</surname> <given-names>T.</given-names></name> <name><surname>Alonso</surname> <given-names>G. D.</given-names></name></person-group> (<year>2017</year>). <article-title>The phosphatidylinositol 3-kinase class III complex containing TcVps15 and TcVps34 participates in autophagy in <italic>Trypanosoma cruzi</italic></article-title>. <source>J. Eukaryot. Microbiol.</source> <volume>64</volume>, <fpage>308</fpage>&#x2013;<lpage>321</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jeu.12367</pub-id>, PMID: <pub-id pub-id-type="pmid">27603757</pub-id></citation></ref>
<ref id="ref127"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schurigt</surname> <given-names>U.</given-names></name> <name><surname>Schad</surname> <given-names>C.</given-names></name> <name><surname>Glowa</surname> <given-names>C.</given-names></name> <name><surname>Baum</surname> <given-names>U.</given-names></name> <name><surname>Thomale</surname> <given-names>K.</given-names></name> <name><surname>Schnitzer</surname> <given-names>J. K.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Aziridine-2,3-dicarboxylate-based cysteine cathepsin inhibitors induce cell death in Leishmania major associated with accumulation of debris in autophagy-related lysosome-like vacuoles</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>54</volume>, <fpage>5028</fpage>&#x2013;<lpage>5041</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.00327-10</pub-id>, PMID: <pub-id pub-id-type="pmid">20855728</pub-id></citation></ref>
<ref id="ref128"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sears</surname> <given-names>S. D.</given-names></name> <name><surname>O&#x2019;Hare</surname> <given-names>J.</given-names></name></person-group> (<year>1988</year>). <article-title>In vitro susceptibility of <italic>Trichomonas vaginalis</italic> to 50 antimicrobial agents</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>32</volume>, <fpage>144</fpage>&#x2013;<lpage>146</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.32.1.144</pub-id>, PMID: <pub-id pub-id-type="pmid">3258142</pub-id></citation></ref>
<ref id="ref129"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Secor</surname> <given-names>W. E.</given-names></name></person-group> (<year>2012</year>). <article-title><italic>Trichomonas vaginalis</italic>: treatment questions and challenges</article-title>. <source>Expert Rev. Anti-Infect. Ther.</source> <volume>10</volume>, <fpage>107</fpage>&#x2013;<lpage>109</lpage>. doi: <pub-id pub-id-type="doi">10.1586/eri.11.159</pub-id></citation></ref>
<ref id="ref130"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sengupta</surname> <given-names>S.</given-names></name> <name><surname>Chowdhury</surname> <given-names>S.</given-names></name> <name><surname>BoseDasgupta</surname> <given-names>S.</given-names></name> <name><surname>Wright</surname> <given-names>C. W.</given-names></name> <name><surname>Majumder</surname> <given-names>H. K.</given-names></name></person-group> (<year>2011</year>). <article-title>Cryptolepine-induced cell death of <italic>Leishmania donovani</italic> promastigotes is augmented by inhibition of autophagy</article-title>. <source>Mol. Biol. Int.</source> <volume>2011</volume>:<fpage>187850</fpage>. doi: <pub-id pub-id-type="doi">10.4061/2011/187850</pub-id>, PMID: <pub-id pub-id-type="pmid">22091398</pub-id></citation></ref>
<ref id="ref131"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheiner</surname> <given-names>L.</given-names></name> <name><surname>Vaidya</surname> <given-names>A. B.</given-names></name> <name><surname>McFadden</surname> <given-names>G. I.</given-names></name></person-group> (<year>2013</year>). <article-title>The metabolic roles of the endosymbiotic organelles of <italic>Toxoplasma</italic> and <italic>Plasmodium</italic> spp.</article-title> <source>Curr. Opin. Microbiol.</source> <volume>16</volume>, <fpage>452</fpage>&#x2013;<lpage>458</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mib.2013.07.003</pub-id>, PMID: <pub-id pub-id-type="pmid">23927894</pub-id></citation></ref>
<ref id="ref132"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shimokawa</surname> <given-names>C.</given-names></name> <name><surname>Kabir</surname> <given-names>M.</given-names></name> <name><surname>Taniuchi</surname> <given-names>M.</given-names></name> <name><surname>Mondal</surname> <given-names>D.</given-names></name> <name><surname>Kobayashi</surname> <given-names>S.</given-names></name> <name><surname>Ali</surname> <given-names>I. K.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Entamoeba moshkovskii is associated with diarrhea in infants and causes diarrhea and colitis in mice</article-title>. <source>J. Infect. Dis.</source> <volume>206</volume>, <fpage>744</fpage>&#x2013;<lpage>751</lpage>. doi: <pub-id pub-id-type="doi">10.1093/infdis/jis414</pub-id>, PMID: <pub-id pub-id-type="pmid">22723640</pub-id></citation></ref>
<ref id="ref133"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shintani</surname> <given-names>T.</given-names></name> <name><surname>Klionsky</surname> <given-names>D. J.</given-names></name></person-group> (<year>2004</year>). <article-title>Autophagy in health and disease: a double-edged sword</article-title>. <source>Science</source> <volume>306</volume>, <fpage>990</fpage>&#x2013;<lpage>995</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.1099993</pub-id>, PMID: <pub-id pub-id-type="pmid">15528435</pub-id></citation></ref>
<ref id="ref134"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shirley</surname> <given-names>D. T.</given-names></name> <name><surname>Farr</surname> <given-names>L.</given-names></name> <name><surname>Watanabe</surname> <given-names>K.</given-names></name> <name><surname>Moonah</surname> <given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>A review of the global burden, new diagnostics, and current therapeutics for Amebiasis</article-title>. <source>Open Forum Infect. Dis.</source> <volume>5</volume>:<fpage>ofy161</fpage>. doi: <pub-id pub-id-type="doi">10.1093/ofid/ofy161</pub-id>, PMID: <pub-id pub-id-type="pmid">30046644</pub-id></citation></ref>
<ref id="ref136"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname> <given-names>R. C. M. C.</given-names></name> <name><surname>Fox</surname> <given-names>E. G. P.</given-names></name> <name><surname>Gomes</surname> <given-names>F. M.</given-names></name> <name><surname>Feij&#x00F3;</surname> <given-names>D. F.</given-names></name> <name><surname>Ramos</surname> <given-names>I.</given-names></name> <name><surname>Koeller</surname> <given-names>C. M.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Venom alkaloids against Chagas disease parasite: search for effective therapies</article-title>. <source>Sci. Rep.</source> <volume>10</volume>:<fpage>10642</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-020-67324-8</pub-id>, PMID: <pub-id pub-id-type="pmid">32606423</pub-id></citation></ref>
<ref id="ref137"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>D.</given-names></name> <name><surname>Kannan</surname> <given-names>G.</given-names></name> <name><surname>Coppens</surname> <given-names>I.</given-names></name> <name><surname>Wang</surname> <given-names>F.</given-names></name> <name><surname>Nguyen</surname> <given-names>H. M.</given-names></name> <name><surname>Cerutti</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Toxoplasma TgATG9 is critical for autophagy and long-term persistence in tissue cysts</article-title>. <source>elife</source> <volume>10</volume>:<fpage>e59384</fpage>. doi: <pub-id pub-id-type="doi">10.7554/eLife.59384</pub-id>, PMID: <pub-id pub-id-type="pmid">33904393</pub-id></citation></ref>
<ref id="ref138"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Souto</surname> <given-names>X. M.</given-names></name> <name><surname>Barbosa</surname> <given-names>H. S.</given-names></name> <name><surname>Menna-Barreto</surname> <given-names>R. F.</given-names></name></person-group> (<year>2016</year>). <article-title>The morphological analysis of autophagy in primary skeletal muscle cells infected with <italic>Toxoplasma gondii</italic></article-title>. <source>Parasitol. Res.</source> <volume>115</volume>, <fpage>2853</fpage>&#x2013;<lpage>2861</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00436-016-5040-3</pub-id>, PMID: <pub-id pub-id-type="pmid">27075305</pub-id></citation></ref>
<ref id="ref139"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swanson</surname> <given-names>M. S.</given-names></name></person-group> (<year>2006</year>). <article-title>Autophagy: eating for good health</article-title>. <source>J. Immunol.</source> <volume>177</volume>, <fpage>4945</fpage>&#x2013;<lpage>4951</lpage>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.177.8.4945</pub-id>, PMID: <pub-id pub-id-type="pmid">17015674</pub-id></citation></ref>
<ref id="ref140"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tomlins</surname> <given-names>A. M.</given-names></name> <name><surname>Ben-Rached</surname> <given-names>F.</given-names></name> <name><surname>Williams</surname> <given-names>R. A.</given-names></name> <name><surname>Proto</surname> <given-names>W. R.</given-names></name> <name><surname>Coppens</surname> <given-names>I.</given-names></name> <name><surname>Ruch</surname> <given-names>U.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Plasmodium falciparum ATG8 implicated in both autophagy and apicoplast formation</article-title>. <source>Autophagy</source> <volume>9</volume>, <fpage>1540</fpage>&#x2013;<lpage>1552</lpage>. doi: <pub-id pub-id-type="doi">10.4161/auto.25832</pub-id></citation></ref>
<ref id="ref141"><citation citation-type="other"><person-group person-group-type="author"><collab id="coll7">United Nations International Children's Emergency Fund</collab></person-group> (<year>2018</year>). Current Status and Progress: Diarrhoea Remains a Leading Killer of Young Children, Despite the Availability of a Simple Treatment Solution. Available at: <ext-link xlink:href="https://data.unicef.org/topic/child-health/diarrhoeal-disease/%23" ext-link-type="uri">https://data.unicef.org/topic/child-health/diarrhoeal-disease/#</ext-link> (Accessed September 18, 2021).</citation></ref>
<ref id="ref142"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uzc&#x00E1;tegui</surname> <given-names>N. L.</given-names></name> <name><surname>Carmona-Guti&#x00E9;rrez</surname> <given-names>D.</given-names></name> <name><surname>Denninger</surname> <given-names>V.</given-names></name> <name><surname>Schoenfeld</surname> <given-names>C.</given-names></name> <name><surname>Lang</surname> <given-names>F.</given-names></name> <name><surname>Figarella</surname> <given-names>K.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Antiproliferative effect of dihydroxyacetone on <italic>Trypanosoma brucei</italic> bloodstream forms: cell cycle progression, subcellular alterations, and cell death</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>51</volume>, <fpage>3960</fpage>&#x2013;<lpage>3968</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.00423-07</pub-id>, PMID: <pub-id pub-id-type="pmid">17682096</pub-id></citation></ref>
<ref id="ref143"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Vaidya</surname> <given-names>A. B.</given-names></name></person-group> (<year>2011</year>). &#x201C;<article-title>Naphthoquinones: atovaquone, and other antimalarials targeting mitochondrial functions,</article-title>&#x201D; in <source>Treatment and Prevention of Malaria.</source> eds. <person-group person-group-type="editor"><name><surname>Staines</surname> <given-names>H.</given-names></name> <name><surname>Krishna</surname> <given-names>S.</given-names></name></person-group> (<publisher-loc>Basel</publisher-loc>: <publisher-name>Springer</publisher-name>), <fpage>127</fpage>&#x2013;<lpage>139</lpage>.</citation></ref>
<ref id="ref144"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van Gerwen</surname> <given-names>O. T.</given-names></name> <name><surname>Muzny</surname> <given-names>C. A.</given-names></name></person-group> (<year>2019</year>). <article-title>Recent advances in the epidemiology, diagnosis, and management of <italic>Trichomonas vaginalis</italic> infection</article-title>. <source>F1000Res.</source> <volume>8</volume>:<fpage>1666</fpage>. doi: <pub-id pub-id-type="doi">10.12688/f1000research.19972.1</pub-id>, PMID: <pub-id pub-id-type="pmid">31583080</pub-id></citation></ref>
<ref id="ref145"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van Vugt</surname> <given-names>M.</given-names></name> <name><surname>van Beest</surname> <given-names>A.</given-names></name> <name><surname>Sicuri</surname> <given-names>E.</given-names></name> <name><surname>van Tulder</surname> <given-names>M.</given-names></name> <name><surname>Grobusch</surname> <given-names>M. P.</given-names></name></person-group> (<year>2011</year>). <article-title>Malaria treatment and prophylaxis in endemic and nonendemic countries: evidence on strategies and their cost&#x2013;effectiveness</article-title>. <source>Future Microbiol.</source> <volume>6</volume>, <fpage>1485</fpage>&#x2013;<lpage>1500</lpage>. doi: <pub-id pub-id-type="doi">10.2217/fmb.11.138</pub-id>, PMID: <pub-id pub-id-type="pmid">22122444</pub-id></citation></ref>
<ref id="ref146"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Vannier-Santos</surname> <given-names>M. A.</given-names></name> <name><surname>Brunoro</surname> <given-names>G. F.</given-names></name> <name><surname>Soeiro</surname> <given-names>M. N. C.</given-names></name> <name><surname>DeCastro</surname> <given-names>S. L.</given-names></name> <name><surname>Menna-Barreto</surname> <given-names>R.</given-names></name></person-group> (<year>2019</year>). &#x201C;<article-title>Parasite, compartments and molecules: trick vs. treatment on Chagas disease</article-title>,&#x201D; in <source>Biology of <italic>Trypanosoma cruzi</italic>.</source> ed. <person-group person-group-type="editor"><name><surname>de</surname> <given-names>W.</given-names> <prefix>Souza</prefix></name></person-group> (<publisher-loc>London</publisher-loc>: <publisher-name>IntechOpen</publisher-name>).</citation></ref>
<ref id="ref147"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vannier-Santos</surname> <given-names>M. A.</given-names></name> <name><surname>Urbina</surname> <given-names>J. A.</given-names></name> <name><surname>Martiny</surname> <given-names>A.</given-names></name> <name><surname>Neves</surname> <given-names>A.</given-names></name> <name><surname>de Souza</surname> <given-names>W.</given-names></name></person-group> (<year>1995</year>). <article-title>Alterations induced by the antifungal compounds ketoconazole and terbinafine in Leishmania</article-title>. <source>J. Eukaryot. Microbiol.</source> <volume>42</volume>, <fpage>337</fpage>&#x2013;<lpage>346</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1550-7408.1995.tb01591.x</pub-id>, PMID: <pub-id pub-id-type="pmid">7620457</pub-id></citation></ref>
<ref id="ref148"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vanrell</surname> <given-names>M. C.</given-names></name> <name><surname>Losinno</surname> <given-names>A. D.</given-names></name> <name><surname>Cueto</surname> <given-names>J. A.</given-names></name> <name><surname>Balcazar</surname> <given-names>D.</given-names></name> <name><surname>Fraccaroli</surname> <given-names>L. V.</given-names></name> <name><surname>Carrillo</surname> <given-names>C.</given-names></name></person-group> (<year>2017</year>). <article-title>The regulation of autophagy differentially affects <italic>Trypanosoma cruzi</italic> metacyclogenesis</article-title>. <source>PLoS Negl. Trop. Dis.</source> <volume>11</volume>:<fpage>e0006049</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pntd.0006049</pub-id>, PMID: <pub-id pub-id-type="pmid">29091711</pub-id></citation></ref>
<ref id="ref149"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Varberg</surname> <given-names>J. M.</given-names></name> <name><surname>LaFavers</surname> <given-names>K. A.</given-names></name> <name><surname>Arrizabalaga</surname> <given-names>G.</given-names></name> <name><surname>Sullivan</surname> <given-names>W. J. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Characterization of plasmodium Atg3-Atg8 interaction inhibitors identifies novel alternative mechanisms of action in <italic>Toxoplasma gondii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>62</volume>, <fpage>e01489</fpage>&#x2013;<lpage>e01417</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.01489-17</pub-id></citation></ref>
<ref id="ref150"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Veiga-Santos</surname> <given-names>P.</given-names></name> <name><surname>Desoti</surname> <given-names>V. C.</given-names></name> <name><surname>Miranda</surname> <given-names>N.</given-names></name> <name><surname>Ueda-Nakamura</surname> <given-names>T.</given-names></name> <name><surname>Dias-Filho</surname> <given-names>B. P.</given-names></name> <name><surname>Silva</surname> <given-names>S. O.</given-names></name></person-group> (<year>2013</year>). <article-title>The natural compounds piperovatine and piperlonguminine induce autophagic cell death on <italic>Trypanosoma cruzi</italic></article-title>. <source>Acta Trop.</source> <volume>125</volume>, <fpage>349</fpage>&#x2013;<lpage>356</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.actatropica.2012.11.014</pub-id>, PMID: <pub-id pub-id-type="pmid">23228524</pub-id></citation></ref>
<ref id="ref151"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vercesi</surname> <given-names>A. E.</given-names></name> <name><surname>Docampo</surname> <given-names>R.</given-names></name></person-group> (<year>1992</year>). <article-title>Ca<sup>2+</sup> transport by digitonin-permeabilized <italic>Leishmania donovani</italic>. Effects of Ca<sup>2+</sup>, pentamidine and WR-6026 on mitochondrial membrane potential in situ</article-title>. <source>Biochem. J.</source> <volume>284</volume>, <fpage>463</fpage>&#x2013;<lpage>467</lpage>. doi: <pub-id pub-id-type="doi">10.1042/bj2840463</pub-id>, PMID: <pub-id pub-id-type="pmid">1376113</pub-id></citation></ref>
<ref id="ref152"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vickerman</surname> <given-names>K.</given-names></name> <name><surname>Tetley</surname> <given-names>L.</given-names></name></person-group> (<year>1977</year>). <article-title>Recent ultrastructural studies on trypanosomes</article-title>. <source>Ann. Soc. Belg. Med. Trop.</source> <volume>57</volume>, <fpage>441</fpage>&#x2013;<lpage>457</lpage>. PMID: <pub-id pub-id-type="pmid">610620</pub-id></citation></ref>
<ref id="ref153"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Viitanen</surname> <given-names>J.</given-names></name> <name><surname>Haataja</surname> <given-names>H.</given-names></name> <name><surname>M&#x00E4;nnist&#x00F6;</surname> <given-names>P. T.</given-names></name></person-group> (<year>1985</year>). <article-title>Concentrations of metronidazole and tinidazole in male genital tissues</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>28</volume>, <fpage>812</fpage>&#x2013;<lpage>814</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.28.6.812</pub-id>, PMID: <pub-id pub-id-type="pmid">4083864</pub-id></citation></ref>
<ref id="ref154"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>White</surname> <given-names>N. J.</given-names></name></person-group> (<year>1996</year>). <article-title>The treatment of malaria</article-title>. <source>N. Engl. J. Med.</source> <volume>335</volume>, <fpage>800</fpage>&#x2013;<lpage>806</lpage>. doi: <pub-id pub-id-type="doi">10.1056/nejm199609123351107</pub-id></citation></ref>
<ref id="ref155"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>White</surname> <given-names>N. J.</given-names></name> <name><surname>van Vugt</surname> <given-names>M.</given-names></name> <name><surname>Ezzet</surname> <given-names>F.</given-names></name></person-group> (<year>1999</year>). <article-title>Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine</article-title>. <source>Clin. Pharmacokinet.</source> <volume>37</volume>, <fpage>105</fpage>&#x2013;<lpage>125</lpage>. doi: <pub-id pub-id-type="doi">10.2165/00003088-199937020-00002</pub-id>, PMID: <pub-id pub-id-type="pmid">10496300</pub-id></citation></ref>
<ref id="ref156"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname> <given-names>S. R.</given-names></name> <name><surname>Taylor</surname> <given-names>M. C.</given-names></name> <name><surname>Horn</surname> <given-names>D.</given-names></name> <name><surname>Kelly</surname> <given-names>J. M.</given-names></name> <name><surname>Cheeseman</surname> <given-names>I.</given-names></name></person-group> (<year>2008</year>). <article-title>A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>105</volume>, <fpage>5022</fpage>&#x2013;<lpage>5027</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0711014105</pub-id>, PMID: <pub-id pub-id-type="pmid">18367671</pub-id></citation></ref>
<ref id="ref157"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname> <given-names>A.</given-names></name> <name><surname>Jahreiss</surname> <given-names>L.</given-names></name> <name><surname>Sarkar</surname> <given-names>S.</given-names></name> <name><surname>Saiki</surname> <given-names>S.</given-names></name> <name><surname>Menzies</surname> <given-names>F. M.</given-names></name> <name><surname>Ravikumar</surname> <given-names>B.</given-names></name></person-group> (<year>2006</year>). <article-title>Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications</article-title>. <source>Curr. Top. Dev. Biol.</source> <volume>76</volume>, <fpage>89</fpage>&#x2013;<lpage>101</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0070-2153(06)76003-3</pub-id></citation></ref>
<ref id="ref158"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname> <given-names>R. A. M.</given-names></name> <name><surname>Smith</surname> <given-names>T. K.</given-names></name> <name><surname>Cull</surname> <given-names>B.</given-names></name> <name><surname>Mottram</surname> <given-names>J. C.</given-names></name> <name><surname>Coombs</surname> <given-names>G. H.</given-names></name></person-group> (<year>2012</year>). <article-title>ATG5 is essential for ATG8-dependent autophagy and mitochondrial homeostasis in <italic>Leishmania</italic> major</article-title>. <source>PLoS Pathog.</source> <volume>8</volume>:<fpage>e1002695</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1002695</pub-id>, PMID: <pub-id pub-id-type="pmid">22615560</pub-id></citation></ref>
<ref id="ref159"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname> <given-names>R. A. M.</given-names></name> <name><surname>Woods</surname> <given-names>K. L.</given-names></name> <name><surname>Juliano</surname> <given-names>L.</given-names></name> <name><surname>Mottram</surname> <given-names>J. C.</given-names></name> <name><surname>Coombs</surname> <given-names>G. H.</given-names></name></person-group> (<year>2009</year>). <article-title>Characterization of unusual families of ATG8-like proteins and ATG12 in the protozoan parasite <italic>Leishmania</italic> major</article-title>. <source>Autophagy</source> <volume>5</volume>, <fpage>159</fpage>&#x2013;<lpage>172</lpage>. doi: <pub-id pub-id-type="doi">10.4161/auto.5.2.7328</pub-id></citation></ref>
<ref id="ref160"><citation citation-type="other"><person-group person-group-type="author"><collab id="coll8">World Health Organization</collab></person-group> (<year>2015</year>). Investing to Overcome the Global Impact of Neglected Tropical Diseases: Third WHO Report on Neglected Diseases 2015. Available at: <ext-link xlink:href="https://apps.who.int/iris/handle/10665/152781" ext-link-type="uri">https://apps.who.int/iris/handle/10665/152781</ext-link> (Accessed March 20, 2021).</citation></ref>
<ref id="ref161"><citation citation-type="other"><person-group person-group-type="author"><collab id="coll9">World Health Organization</collab></person-group> (<year>2020a</year>). Chagas Disease (American Trypanosomiasis). Fact Sheet. Available at: <ext-link xlink:href="https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis)" ext-link-type="uri">https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis)</ext-link> (Accessed March 12, 2020).</citation></ref>
<ref id="ref162"><citation citation-type="other"><person-group person-group-type="author"><collab id="coll10">World Health Organization</collab></person-group> (<year>2020b</year>). World Malaria Report. Fact Sheet. Available at: <ext-link xlink:href="https://www.who.int/teams/global-malaria-programme" ext-link-type="uri">https://www.who.int/teams/global-malaria-programme</ext-link> (Accessed September 19, 2020).</citation></ref>
<ref id="ref163"><citation citation-type="other"><person-group person-group-type="author"><collab id="coll11">World Health Organization</collab></person-group> (<year>2022</year>). Trypanosomiasis, Human African (Sleeping Sickness). Fact Sheet. Available at: <ext-link xlink:href="https://www.who.int/news-room/fact-sheets/detail/trypanosomiasis-human-african-(sleeping-sickness)" ext-link-type="uri">https://www.who.int/news-room/fact-sheets/detail/trypanosomiasis-human-african-(sleeping-sickness)</ext-link> (Accessed Jan 22, 2022).</citation></ref>
<ref id="ref164"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>J. H.</given-names></name> <name><surname>Tung</surname> <given-names>S. Y.</given-names></name> <name><surname>Ho</surname> <given-names>C. C.</given-names></name> <name><surname>Su</surname> <given-names>L. H.</given-names></name> <name><surname>Gan</surname> <given-names>S. W.</given-names></name> <name><surname>Liao</surname> <given-names>J. Y.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>A myeloid leukemia factor homolog involved in encystation-induced protein metabolism in <italic>Giardia lamblia</italic></article-title>. <source>Biochim. Biophys. Acta Gen. Subj.</source> <volume>1865</volume>:<fpage>129859</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbagen.2021.129859</pub-id>, PMID: <pub-id pub-id-type="pmid">33581252</pub-id></citation></ref>
<ref id="ref165"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>J.</given-names></name> <name><surname>Si</surname> <given-names>H.</given-names></name> <name><surname>Lv</surname> <given-names>K.</given-names></name> <name><surname>Qiu</surname> <given-names>Y.</given-names></name> <name><surname>Sun</surname> <given-names>J.</given-names></name> <name><surname>Bai</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Licarin-B exhibits activity against the <italic>Toxoplasma gondii</italic> RH strain by damaging mitochondria and activating autophagy</article-title>. <source>Front. Cell Dev. Biol.</source> <volume>9</volume>:<fpage>684393</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcell.2021.684393</pub-id>, PMID: <pub-id pub-id-type="pmid">34179016</pub-id></citation></ref>
<ref id="ref166"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Zulfiqar</surname> <given-names>H.</given-names></name> <name><surname>Mathew</surname> <given-names>G.</given-names></name> <name><surname>Horrall</surname> <given-names>S.</given-names></name></person-group> (<year>2021</year>). <source>Amebiasis.</source> <publisher-loc>Treasure Island (FL)</publisher-loc>: <publisher-name>StatPearls</publisher-name>.</citation></ref>
</ref-list>
</back>
</article>